- Condition: Adolescent Immunizations Among Clinic Population
Intervention:
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill
Not yet recruiting - verified April 2012 - Conditions: Kallmann Syndrome; Hypogonadotropic Hypogonadism; Hypothalamic Amenorrhea; Polycystic Ovarian Syndrome; Precocious Puberty
Intervention:
Sponsors: Centre Hospitalier Universitaire Vaudois; Centre Hospitalier Universitaire Vaudois; Swiss National Science Foundation
Recruiting - verified May 2012 - Condition: Hepatic Impairment
Intervention: Drug: telaprevir
Sponsors: Janssen Infectious Diseases BVBA; Janssen Infectious Diseases BVBA
Not yet recruiting - verified May 2012 - Condition: HIV Dementia
Interventions: Drug: Lipitor; Drug: placebo
Sponsors: University of Pennsylvania; University of Pennsylvania
Not yet recruiting - verified May 2012 - Conditions: HIV Infection; Tuberculosis
Interventions: Drug: Lopinavir/Ritonavir; Drug: Lopinavir/Ritonavir; Drug: Raltegravir; Drug: Isoniazid; Drug: Pyridoxine; Drug: Pyrazinamide; Drug: Ethambutol; Drug: Rifabutin; Drug: Rifampin
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified May 2012 - Conditions: Heart Failure; Endothelium
Intervention: Drug: Urocortin 2, Urocortin 3 and Substance P
Sponsors: University of Edinburgh; University of Edinburgh; NHS Lothian
Not yet recruiting - verified May 2012 - Condition: Breast Cancer
Intervention:
Sponsors: Genentech; Genentech; 23andMe, Inc.
Recruiting - verified May 2012 - Condition: HIV Dementia
Interventions: Drug: Long acting methylphenidate; Drug: Long acting methylphenidate; Drug: Matched placebo
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified May 2012 - Condition: Erectile Dysfunction
Intervention: Device: Low Intensity Extracorporeal Shock waves (Cardiospec 1000)
Sponsors: Rambam Health Care Campus; Rambam Health Care Campus
Not yet recruiting - verified May 2012 - Condition: Erectile Dysfunction
Intervention: Device: LipiVage and Cell Isolation System
Sponsors: American Medical Systems; American Medical Systems
Not yet recruiting - verified May 2012 - Condition: Cancer
Intervention:
Sponsors: Rambam Health Care Campus; Rambam Health Care Campus
Not yet recruiting - verified April 2012 - Condition: Hepatic Impairment
Intervention: Drug: LCQ908
Sponsors: Novartis; Novartis
Recruiting - verified May 2012 - Condition: Human Immunodeficiency Virus
Interventions: Drug: Atazanavir, ritonavir, lamivudine; Drug: Atazanavir, Ritonavir, 2 NRTIs
Sponsors: Catholic University of the Sacred Heart; Catholic University of the Sacred Heart
Recruiting - verified May 2012 - Condition: Cardiovascular Disease
Intervention:
Sponsors: Queen Mary University of London; Queen Mary University of London; King's College London
Not yet recruiting - verified April 2012 - Conditions: Muscle Atrophy; ACL Reconstruction; Trauma; Osteoarthritis
Interventions: Drug: Testosterone; Drug: Saline
Sponsors: University of Southern California; University of Southern California; Boston University; University of Oregon
Recruiting - verified May 2012 - Condition: Condylomata Acuminata
Intervention:
Sponsors: University of Buenos Aires; University of Buenos Aires
Not yet recruiting - verified May 2012 - Condition: Uterine Prolapse
Interventions: Procedure: Laparoscopic supracervical hysterectomy with sacropexy; Procedure: Vaginal hysterectomy with uterosacral colposuspension
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital
Not yet recruiting - verified May 2012 - Condition: Vestibulodynia
Intervention: Behavioral: Cognitive-behavioral couple therapy (CBCT)
Sponsors: Université de Montréal; Université de Montréal
Not yet recruiting - verified May 2012 - Condition: Inflammatory Bowel Disease
Intervention: Drug: Iron Isomaltoside 1000
Sponsors: Pharmacosmos A/S; Pharmacosmos A/S; Max Neeman International; Pharma Consulting Group
Not yet recruiting - verified May 2012 - Conditions: Back Pain; Osteoarthritis
Interventions: Other: Opioid-intensive prescribing strategy; Other: Opioid-avoidant prescribing strategy
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified April 2012 - Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1265744 Oral; Drug: GSK1265744 LAP 800mg intramuscular injection; Drug: GSK1265744 LAP 200mg subcutaneous injection; Drug: GSK1265744 LAP 200mg intramuscular injection; Drug: GSK1265744 LAP 400mg intramuscular injection; Drug: TMC278 LA 1200mg intramuscular injection; Drug: TMC278 LA 600mg intramuscular injection; Drug: GSK1265744 LAP 800mg intramuscular injection
Sponsors: ViiV Healthcare; ViiV Healthcare; GlaxoSmithKline
Not yet recruiting - verified May 2012 - Condition: Rectal Cancer
Interventions: Procedure: TME; Procedure: TME; Procedure: Neuromonitoring
Sponsors: Johannes Gutenberg University Mainz; Johannes Gutenberg University Mainz
Not yet recruiting - verified April 2012 - Condition: Cardiovascular Function
Intervention: Biological: Typhoid vaccine
Sponsors: Queen Mary University of London; Queen Mary University of London
Recruiting - verified April 2012 - Condition: Uncomplicated Urogenital Gonorrhea
Intervention: Drug: solithromycin
Sponsors: Cempra Pharmaceuticals; Cempra Pharmaceuticals
Recruiting - verified May 2012 - Condition: Peyronie's Disease
Interventions: Drug: Vitamin D2; Drug: Vitamin E; Drug: Testosterone Pellets
Sponsors: Men's Health Boston; Men's Health Boston
Recruiting - verified April 2012 - Conditions: Cancer Survivor; Breast Cancer; Colorectal Cancer; Gynecological Cancer; Ovarian Cancer; Uterine Cancer
Intervention: Behavioral: Mindfulness Based Cancer Recovery
Sponsors: Masonic Cancer Center, University of Minnesota; Masonic Cancer Center, University of Minnesota
Not yet recruiting - verified May 2012 - Condition: Granulosa Cell Tumour of the Ovary
Intervention: Drug: Ketoconazole
Sponsors: Grupo Español de Tumores Huérfanos e Infrecuentes; Grupo Español de Tumores Huérfanos e Infrecuentes
Not yet recruiting - verified April 2012 - Condition: HIV Infections
Intervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine
Sponsors: Harvard School of Public Health; Harvard School of Public Health; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified April 2012 - Conditions: Post Traumatic Stress Disorder; Anxiety; Depression; Conduct Disorder; ADHD
Intervention:
Sponsors: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Recruiting - verified May 2012 - Condition: Nicotine Dependence
Interventions: Drug: Oxytocin; Drug: placebo
Sponsors: Medical University of South Carolina; Kevin Gray
Not yet recruiting - verified April 2012 - Condition: HIV Infections
Interventions: Biological: HIV-MAG vaccine; Biological: IL-12 pDNA adjuvant; Biological: VSV HIV gag vaccine; Biological: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified May 2012 - Conditions: Arthralgia; Breast Cancer; Hot Flashes; Musculoskeletal Complications; Sexual Dysfunction
Interventions: Drug: therapeutic testosterone; Other: placebo
Sponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)
Not yet recruiting - verified April 2012 - Condition: Nicotine Dependence
Intervention: Drug: Intravenous Nicotine
Sponsors: Mclean Hospital; Mclean Hospital; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2012 - Condition: Sexual Transmission of Infection
Interventions: Behavioral: HIV prevention intervention; Behavioral: Diet and Nutrition; Other: Standard of care
Sponsors: Children's Memorial Hospital; Children's Memorial Hospital; National Institute of Mental Health (NIMH)
Recruiting - verified April 2012 - Conditions: Chromosome 13 Aneuploidy; Chromosome 18 Aneuploidy; Chromosome 21 Aneuploidy; Sex Chromosome Aberrations; Other Microdeletions
Interventions: Procedure: Blood draw; Procedure: Cheek swab/Saliva Sampling
Sponsors: Natera, Inc.; Natera, Inc.
Recruiting - verified April 2012 - Condition: Monckeberg Medial Calcific Sclerosis
Intervention:
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified April 2012 - Conditions: Klinefelter Syndrome; XXY Syndrome
Interventions: Drug: Testosterone gel 1%; Drug: Placebo gel
Sponsors: University of Colorado, Denver; University of Colorado, Denver; Colorado Clinical & Translational Sciences Institute; Children's Hospital Colorado; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified April 2012 - Condition: HIV Infections
Interventions: Biological: GEO-D03 DNA vaccine; Biological: MVA/HIV62B (MVA62B) vaccine; Biological: Placebo for GEO-D03 DNA; Biological: Placebo for MVA62B:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); GeoVax, Inc.
Not yet recruiting - verified May 2012 - Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: dolutegravir 50 mg twice daily; Drug: dolutegravir placebo twice daily; Drug: Open-label dolutegravir 50mg twice daily
Sponsors: ViiV Healthcare; ViiV Healthcare; Shionogi; GlaxoSmithKline
Recruiting - verified May 2012 - Conditions: Substance-related Disorders; HIV Risk Behavior
Interventions: Behavioral: Therapeutic Workplace; Drug: Methadone
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified March 2012 - Condition: HIV Infection
Interventions: Drug: Tenofovir, Emtricitabine, Lopinavir/r; Drug: Tenofovir, Emtricitabine, Raltegravir
Sponsors: Hospital Clinic of Barcelona; Hospital Clinic of Barcelona
Not yet recruiting - verified April 2012 - Condition: Emergency Contraception
Intervention: Drug: ellaOne
Sponsors: HRA Pharma; HRA Pharma
Recruiting - verified March 2012 - Condition: Emergency Contraception
Interventions: Drug: Ulipristal Acetate (UPA) + ethinylestradiol/levonorgestrel (Microgynon); Drug: placebo + ethinylestradiol/levonorgestrel
Sponsors: HRA Pharma; HRA Pharma
Recruiting - verified March 2012 - Conditions: Acquired Immunodeficiency Syndrome; HIV Infections
Interventions: Drug: darunavir/cobicistat/emtricitabine/GS-7340; Drug: darunavir + cobicistat + emtricitabine/tenofovir df
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified April 2012 - Conditions: Type 2 Diabetes Mellitus; Hypogonadism
Interventions: Drug: Testosterone; Drug: Placebo
Sponsors: Odense University Hospital; Marianne Andersen; Odense University Hospital
Recruiting - verified March 2012 - Conditions: Pemphigoid, Bullous; Pemphigus; Lupus Erythematosus, Cutaneous
Intervention:
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified March 2012 - Condition: Sexually Transmitted Diseases
Interventions: Behavioral: Horizons+General Health Promotion (GHP); Behavioral: Horizons+Motivational Enhancement Therapy (GMET)
Sponsors: Emory University; Emory University
Recruiting - verified March 2012 - Condition: Huntington Disease
Intervention:
Sponsors: Seoul National University Hospital; Seoul National University Hospital; European Huntington's Disease Network
Recruiting - verified March 2012 - Condition: Sexually Transmitted Diseases
Intervention:
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham
Recruiting - verified April 2012 - Conditions: Hepatitis C; HIV
Interventions: Drug: PSI-7977; Drug: Efavirenz; Drug: Tenofovir; Drug: Emtricitabine; Drug: Atazanavir plus Ritonavir; Drug: Zidovudine; Drug: Lamivudine
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified March 2012 - Conditions: Tetraplegia; Plegia; Paresis; Cervical Spinal Cord Injury
Intervention: Procedure: Nerve reconstruction
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified April 2012 - Condition: Urge Urinary Incontinence
Intervention: Drug: solifenacin succinate
Sponsors: Loyola University; Loyola University; Astellas Pharma US, Inc.
Recruiting - verified April 2012 - Condition: Rectal Neoplasm
Interventions: Procedure: Robotic surgery; Procedure: Laparoscopic surgery
Sponsors: National Cancer Center, Korea; National Cancer Center, Korea
Recruiting - verified May 2012 - Conditions: Pregnancy; Sexually Transmitted Infections
Interventions: Behavioral: BUtiful. Be yoU! Talented, Informed, Fearless, Uncompromised, Loved; Behavioral: DIVAS. Diversity, Individuality, Vitality, Activity and Strong.
Sponsors: Tulane University Health Sciences Center; Tulane University Health Sciences Center; Department of Health and Human Services
Not yet recruiting - verified April 2012 - Conditions: Sickle Cell Disease; Sickle Cell Anemia; Anemia, Sickle Cell
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2012 - Condition: Sexually Transmitted Infections
Intervention:
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; University of Mississippi Medical Center
Recruiting - verified March 2012 - Conditions: Inflammation; Macrophage Infiltration; Cardiovascular Disease
Interventions: Drug: Sitagliptin; Drug: Placebo
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Not yet recruiting - verified March 2012 - Condition: Renal Impairment
Intervention: Drug: LCQ908
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified March 2012 - Conditions: Palpebral Pathologies; Ocular Surface Disease; Meibomian Gland Dysfunction
Intervention:
Sponsors: Laboratoires Thea; Laboratoires Thea; IRIS Pharma; AIXIAL
Not yet recruiting - verified March 2012 - Condition: HIV-Associated Cognitive Motor Complex
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified December 2011 - The Effect of Transvaginal vs. Conventional Laparoscopic Cholecystectomy on the Postoperative CourseConditions: Cholecystolithiasis; Surgery; Pain
Intervention: Procedure: TV NOTES cholecystectomy
Sponsors: Herlev Hospital; Herlev Hospital; University of Copenhagen; University Hospital, Gentofte, Copenhagen; Bispebjerg Hospital
Not yet recruiting - verified April 2012 - Condition: Internalizing and Externalizing Symptoms in Pediatric Population as Measures by Child Behavior Checklist
Interventions: Behavioral: Dialectical Behavior Therapy Adapted for children; Behavioral: Supportive-Educational therapy
Sponsors: Yale University; Yale University; Green Chimneys Residential Treatment Center, Brewster, NY
Recruiting - verified March 2012 - Conditions: Pelvic Organ Prolapse; Urinary Incontinence; Fecal Incontinence
Intervention:
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified February 2012 - Conditions: Wart; External Genital Organs; Condyloma Acuminata
Intervention: Drug: Topical AS101
Sponsors: BioMAS Ltd; BioMAS Ltd
Not yet recruiting - verified March 2012 - Condition: HIV-1 Infection
Intervention: Drug: Sevelamer carbonate
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Conditions: Pelvic Organ Prolapse; Urinary Incontinence; Fecal Incontinence
Intervention:
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified February 2012 - Condition: Compensated Heart Failure
Interventions: Drug: torasemide-PR; Drug: Furosemide-IR; Drug: torasemide-IR
Sponsors: Ferrer Internacional S.A.; Ferrer Internacional S.A.
Recruiting - verified March 2012 - Conditions: HIV; Malnutrition
Intervention: Other: Multi-sectoral agricultural intervention
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institute of Mental Health (NIMH); Kenya Medical Research Institute; University of California, Davis
Not yet recruiting - verified April 2012 - Condition: Influenza
Interventions: Biological: Intradermal vaccine; Biological: Intramuscular vaccine
Sponsors: Centers for Disease Control and Prevention; Centers for Disease Control and Prevention; Ministry of Health, Thailand
Recruiting - verified February 2012 - Condition: Esophageal Cancer
Intervention: Device: wireless pulse oximeter (Wipox)
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified March 2012 - Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Anastrozole; Drug: Placebo
Sponsors: University of Pennsylvania; University of Pennsylvania
Not yet recruiting - verified February 2012 - Condition: Deep Partial Thickness Burn
Interventions: Drug: Epidermal growth factor with silver sulfadiazine cream; Drug: Silver zinc sulfadiazine cream
Sponsors: Chulalongkorn University; Chulalongkorn University; National Science and Technology Development Agency, Thailand
Recruiting - verified March 2012 - Condition: HIV Infection
Intervention: Drug: stop statin and switch to an antiretroviral drug with less impact on lipid metabolism
Sponsors: University Hospital, Geneva; Calmy Alexandra; Janssen-Cilag A.G., Switzerland
Recruiting - verified February 2012 - Condition: HIV-1 Infection
Interventions: Biological: VAC-3S; Biological: Placebo
Sponsors: InnaVirVax; InnaVirVax
Recruiting - verified March 2012 - Condition: HIV Infections
Interventions: Drug: Dapivirine Vaginal Film; Drug: Dapivirine Vaginal Gel
Sponsors: International Partnership for Microbicides, Inc.; International Partnership for Microbicides, Inc.
Not yet recruiting - verified March 2012 - Conditions: Anemia; Intestinal Helminthiasis; Intestinal Schistosomiasis; Human Immunodeficiency Virus I Infection; Hematologic Diseases; Opportunistic Infections
Interventions: Drug: Praziquantel and Albendazole; Drug: Praziquantel and Albendazole; Drug: Praziquantel and Albendazole
Sponsors: Catholic University of Health and Allied Sciences; Catholic University of Health and Allied Sciences; National Institute for Medical Research, Tanzania; University of Cambridge
Not yet recruiting - verified March 2012 - Condition: Pedophilia
Intervention: Behavioral: neuropsychological questionnaires
Sponsors: University Hospital, Montpellier; University Hospital, Montpellier
Recruiting - verified February 2012 - Condition: HIV Prevention
Interventions: Other: Testing and Counseling; Behavioral: Brief Motivational Interviewing; Behavioral: Integrated Family and Cognitive Behavioral Therapy
Sponsors: University of Florida; University of Florida; National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2012 - Conditions: Heart Failure; Sleep Apnea Syndromes
Interventions: Other: Exercise training; Other: Control group; Other: CPAP group; Other: Exercise and CPAP group
Sponsors: Associacao Fundo de Incentivo a Psicofarmcologia; Associacao Fundo de Incentivo a Psicofarmcologia
Recruiting - verified February 2012 - Condition: HIV Prevention
Interventions: Drug: Rectal formulation (RF) of tenofovir 1% gel; Drug: Vaginal formulations (original VF and reduced vaginal glycerin formulation RGVF) of tenofovir 1% gel; Drug: Universal HEC Placebo Gel Formulation
Sponsors: University of Pittsburgh; Ian McGowan; National Institute of Allergy and Infectious Diseases (NIAID); CONRAD
Not yet recruiting - verified April 2012 - Conditions: HIV Positive; Marijuana Smoking
Intervention:
Sponsors: Wayne State University; Wayne State University; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: HIV Infections
Interventions: Drug: Dapivirine; Other: Placebo
Sponsors: International Partnership for Microbicides, Inc.; International Partnership for Microbicides, Inc.
Not yet recruiting - verified February 2012 - Condition: HIV Infection
Intervention: Behavioral: Point of Care CD4 count and peer case management
Sponsors: New York University; New York University; New York University School of Medicine
Not yet recruiting - verified March 2012 - Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: dolutegravir
Sponsors: ViiV Healthcare; ViiV Healthcare; GlaxoSmithKline
Available - verified December 2011 - Condition: HIV Positive
Intervention:
Sponsors: Wayne State University; Wayne State University; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Conditions: Mood Lability; PTSD; Anxiety
Interventions: Behavioral: FamilyLive; Behavioral: Standard Mental Health Treatment
Sponsors: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Substance Abuse and Mental Health Services Administration (SAMHSA)
Recruiting - verified February 2012 - Conditions: Child Abuse; Vaginismus; Dystocia; Depression
Intervention:
Sponsors: Hillel Yaffe Medical Center; Hillel Yaffe Medical Center; The Baruch Padeh Medical Center, Poriya
Not yet recruiting - verified January 2012 - Condition: Fecal Incontinence
Interventions: Device: Medtronic Interstim II-3058; Procedure: Anal bulking injection
Sponsors: University Hospital of North Norway; University Hospital of North Norway
Recruiting - verified March 2012 - Conditions: Emotional Lability; PTSD
Intervention: Behavioral: Yoga Based Movement Therapy
Sponsors: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Substance Abuse and Mental Health Services Administration (SAMHSA)
Recruiting - verified February 2012 - Condition: Cystitis
Interventions: Drug: Norfloxacin; Drug: Cephalosporins; Drug: Cephalosporins
Sponsors: Eurofarma Laboratorios S.A.; Eurofarma Laboratorios S.A.
Not yet recruiting - verified February 2012 - Condition: HIV Infection
Interventions: Drug: Tenofovir, emtricitabine, maraviroc; Drug: Tenofovir, emtricitabine, lopinavir/r
Sponsors: Hospital Clinic of Barcelona; Hospital Clinic of Barcelona
Not yet recruiting - verified February 2012 - Conditions: Adolescent HIV Prevention; Adolescent Unintended Pregnancy
Intervention: Behavioral: combination HIV prevention package for boys and girls
Sponsors: New York University; New York University; University of Nairobi
Not yet recruiting - verified April 2012 - Condition: Colorectal Cancer
Intervention: Device: PillCam Colon Capsule Endoscopy (Given® Diagnostic System)
Sponsors: Catholic University of the Sacred Heart; Catholic University of the Sacred Heart
Recruiting - verified February 2012 - Condition: Female Genital Warts
Intervention:
Sponsors: BEMFAM-Bem Estar Familiar; BEMFAM-Bem Estar Familiar; Merck
Not yet recruiting - verified January 2012 - Conditions: Acquired Immunodeficiency Syndrome; HIV Infections
Intervention: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir df
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified April 2012 - Condition: HIV Infection
Intervention: Other: monetary reinforcer
Sponsors: University of British Columbia; University of British Columbia; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Graft-vs-Host Disease
Intervention:
Sponsors: Hadassah Medical Organization; Hadassah Medical Organization
Not yet recruiting - verified January 2012 - Condition: Benign Prostatic Hyperplasia
Intervention: Procedure: Holmium Laser Enucleation of the Prostate (HoLEP)
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified March 2012 - Condition: Colorectal Cancer
Interventions: Drug: capecitabine; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)
Not yet recruiting - verified January 2012 - Conditions: HIV; Syphilis
Intervention: Device: MBIO POC combined HIV syphilis test ( SnapEsi)
Sponsors: Program for Appropriate Technology in Health; Program for Appropriate Technology in Health; Walter Reed Army Institute of Research (WRAIR); Kenya Medical Research Institute
Recruiting - verified January 2012 - Conditions: Multiple Sclerosis; Fatigue
Interventions: Drug: Testosterone undecanoate; Drug: placebo
Sponsors: Health Sciences Centre, Winnipeg, Manitoba; Health Sciences Centre, Winnipeg, Manitoba; University of Manitoba; Consortium of Multiple Sclerosis Centers; Manitoba Medical Service Foundation
Not yet recruiting - verified January 2012 - Condition: HIV Related Neurocognitive Impairment
Intervention:
Sponsors: St Stephens Aids Trust; St Stephens Aids Trust
Recruiting - verified January 2012 - Conditions: Sexually Transmitted Infection; HIV
Interventions: Behavioral: Tailored Socio-Contextual Intervention; Behavioral: Standard of Care
Sponsors: University of Wisconsin, Milwaukee; University of Wisconsin, Milwaukee; National Institute of Mental Health (NIMH)
Not yet recruiting - verified January 2012 - Condition: HIV Infections
Interventions: Biological: Tat; Biological: Placebo
Sponsors: Istituto Superiore di Sanita; Istituto Superiore di Sanita; Italian Ministry of Foreign Affairs - General Direction for Cooperation and Development
Recruiting - verified January 2012 - Condition: Atherosclerosis
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2012 - Condition: HIV Infection
Interventions: Drug: Maraviroc; Drug: Emtricitabine; Drug: Tenofovir disoproxil fumarate; Other: Maraviroc placebo; Other: Emtricitabine placebo; Other: Tenofovir disoproxil fumarate placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); HIV Prevention Trials Network
Not yet recruiting - verified May 2012 - Condition: Breast Cancer Risk
Interventions: Behavioral: Diet; Behavioral: Combined exercise- + diet-induced weight loss
Sponsors: UMC Utrecht; UMC Utrecht
Not yet recruiting - verified January 2012 - Condition: Depression
Interventions: Drug: Trazodone; Drug: Placebo
Sponsors: Lee's Pharmaceutical Limited; Lee's Pharmaceutical Limited
Recruiting - verified January 2012 - Condition: HIV-1 Infection
Intervention: Drug: Atazanavir/ritonavir monotherapy
Sponsors: Fondazione SanRaffaele del Monte Tabor; Fondazione SanRaffaele del Monte Tabor; Bristol-Myers Squibb
Recruiting - verified January 2012 - Condition: HIV Infections
Intervention:
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Fragile X Syndrome
Interventions: Drug: RO4917523; Drug: RO4917523; Drug: Placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified January 2012 - Condition: Schizophrenia
Intervention: Dietary Supplement: Sarcosine
Sponsors: Medical Universtity of Lodz; Medical Universtity of Lodz
Recruiting - verified February 2012 - Conditions: Substance Use; Sexual Risk Behaviors
Interventions: Behavioral: Risk Reduction Therapy for Adolescents; Behavioral: Usual services
Sponsors: Medical University of South Carolina; Medical University of South Carolina
Recruiting - verified January 2012 - Conditions: HIV; Burkitt's Lymphoma
Interventions: Drug: Induction Phase; Drug: Consolidation Phase (on day +50); Drug: Intensification phase; Drug: BEAM conditioning; Radiation: Consolidation radiotherapy
Sponsors: IRCCS San Raffaele; Andres J. M. Ferreri
Recruiting - verified January 2012 - Conditions: Anogenital Warts; Condylomata Acuminata; Human Papillomavirus Infection
Interventions: Drug: AP611074; Drug: Placebo
Sponsors: Anaconda Pharma; Anaconda Pharma
Recruiting - verified February 2012 - Condition: AIDS/HIV PROBLEM
Intervention:
Sponsors: Gaia Medical Institute; Gaia Medical Institute; AIDS Healthcare Foundation
Recruiting - verified January 2012 - Condition: HIV Infections
Intervention: Drug: Nevirapine, zidovudine, lamivudine
Sponsors: Institut de Recherche pour le Developpement; Institut de Recherche pour le Developpement; Harvard School of Public Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified January 2012 - Condition: HIV Infections
Intervention: Drug: Etravirine (ETR)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified May 2012 - Conditions: Vulvodynia; Dyspareunia; Breast Cancer; Menopause
Intervention: Drug: Topical liquid lidocaine
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Recruiting - verified February 2012 - Conditions: Risk Reduction Behavior; Interpersonal Relations; Mental Disorders
Intervention: Behavioral: individual and group-based, community health worker delivered
Sponsors: Women's College Hospital; Women's College Hospital; NEGES Foundation, Leogane, Haiti; Adelphi University
Not yet recruiting - verified December 2011 - Condition: HIV Infection
Interventions: Drug: Immediate ARV treatment initiation with TDF/FTC/EFV; Other: WHO recommendation guided ARV (TDF/FTC/EFV) initiation
Sponsors: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); Africa Centre For Health and Population Studies, South Africa; University of KwaZulu-Natal, South Africa
Recruiting - verified March 2012 - Conditions: HIV; Sexual Risk; Sexually Transmitted Diseases; Substance Abuse; Violence; Victimization
Interventions: Behavioral: Test, Treat, Retain(TTR) + Women's Health CoOp (WHC); Biological: Test, Treat, Retain(TTR) only
Sponsors: RTI International; RTI International; University of North Carolina, Chapel Hill
Not yet recruiting - verified December 2011 - Conditions: Osteoporosis; Bone Diseases, Metabolic
Intervention: Behavioral: Bone Mineral Density Result Letter and Bone Health Brochure
Sponsors: University of Iowa; University of Iowa; University of Alabama at Birmingham; Kaiser Permanente; University of Pittsburgh
Recruiting - verified March 2012 - Condition: Hepatitis C, Chronic
Interventions: Drug: Telaprevir; Drug: Telaprevir
Sponsors: Janssen-Cilag International NV; Janssen-Cilag International NV
Recruiting - verified April 2012 - Condition: HIV Infections
Interventions: Drug: 1% tenofovir gel; Drug: Placebo gel
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified March 2012 - Condition: Nicotine Addiction
Interventions: Drug: Saline; Drug: Nicotine
Sponsors: Yale University; Yale University
Recruiting - verified December 2011 - Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Dolutegravir
Sponsors: ViiV Healthcare; ViiV Healthcare; Shionogi; GlaxoSmithKline
Recruiting - verified March 2012 - Conditions: Acquired Immunodeficiency Syndrome; HIV Infections
Interventions: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir df; Drug: NNRTI plus FTC/TDF
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified March 2012 - Condition: Pancreatic Cancer
Intervention: Radiation: MeIQx
Sponsors: Masonic Cancer Center, University of Minnesota; Masonic Cancer Center, University of Minnesota
Not yet recruiting - verified January 2012 - Condition: Traumatic Injury
Intervention:
Sponsors: University of Pittsburgh; University of Pittsburgh
Recruiting - verified December 2011 - Conditions: HIV Infections; Tuberculosis
Interventions: Drug: Isoniazid (INH); Drug: Placebo for isoniazid (INH)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified May 2012 - Condition: HIV Infections
Interventions: Drug: Topical GV; Drug: Nystatin Oral Suspension
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: Condylomata Acuminata
Intervention:
Sponsors: Universidad de Valparaiso; Universidad de Valparaiso
Not yet recruiting - verified November 2011 - Condition: HIV-1 Infection
Interventions: Drug: BMS-986001; Drug: BMS-986001; Drug: BMS-986001; Drug: Placebo matching with BMS-986001; Drug: Efavirenz; Drug: Lamivudine; Drug: Tenofovir
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified December 2011 - Conditions: Adrenal Hyperplasia, Congenital; Congenital Hypothyroidism; Cystic Fibrosis
Intervention:
Sponsors: Luminex Molecular Diagnostics; Luminex Corporation
Recruiting - verified January 2012 - Conditions: Tobacco Cessation; HIV; AIDS
Interventions: Behavioral: Treatment as usual; Behavioral: AIR (Aspirations, Inspiration, Respiration)
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Gay Men’s Health Crisis; The City College of New York; AIDS Center of Queens County; Bronx AIDS Services; Bronx Community Pride Center; Brooklyn AIDS Task Force; Fortune Society; Harlem United Community AIDS Center; Iris House; North Jersey Community Research Initiative
Recruiting - verified February 2012 - Condition: HIV Infection
Intervention: Other: monetary reinforcer
Sponsors: University of British Columbia; University of British Columbia; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified December 2011 - Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line ChemotherapyCondition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
Sponsors: Seoul Veterans Hospital; Seoul Veterans Hospital
Recruiting - verified December 2011 - Conditions: HIV Infections; Hepatitis C
Interventions: Drug: Pegylated-Interferon Alfa 2b (PEG-IFN); Drug: Ribavirin (RBV); Drug: Boceprevir (BOC)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified May 2012 - Condition: HIV-1 Infection
Interventions: Biological: Placebos of GTU-multiHIV B and LIPO-5 vaccines; Biological: GTU-multHIV B vaccine and LIPO-5 vaccine
Sponsors: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Not yet recruiting - verified March 2012 - Conditions: Alcohol Use; Marijuana Use; Sexually Transmitted Infections
Interventions: Behavioral: motivational intervention; Behavioral: health education
Sponsors: Butler Hospital; Butler Hospital
Recruiting - verified March 2012 - Condition: HPV-related Head and Neck Cancer
Intervention: Biological: pNGVL-4a-CRT/E7 (detox) DNA vaccine
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Sidney Kimmel Comprehensive Cancer Center; National Institute of Dental and Craniofacial Research (NIDCR); Milton J. Dance, Jr. Head and Neck Center at Greater Baltimore Medical Center; Ichor Medical System Incorporated
Recruiting - verified April 2012 - Condition: HIV Infection
Interventions: Drug: Truvada; Drug: Placebo
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - verified March 2012 - Condition: HIV Infections
Interventions: Biological: VRC rAd5 vaccine (rAd5 gag-pol/env A/B/C); Biological: rAd5 env A; Biological: rAd5 env B; Biological: rAd5 env C; Biological: rAd5 gag-pol; Biological: Placebo Vaccine
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: HIV Infection
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco; Tobira Therapeutics, Inc.
Recruiting - verified January 2012 - Condition: Infection
Intervention: Device: STD Diagnostic Kit (Identigene)
Sponsors: Identigene; Identigene; Lifetree Clinical Research
Recruiting - verified November 2011 - Conditions: Acquired Immunodeficiency Syndrome; HIV Infections
Interventions: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir df; Drug: ritonavir-boosted protease inhibitor plus Truvada
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified March 2012 - Conditions: HIV; Syphilis; Gonorrhea; Chlamydia
Interventions: Behavioral: Mujer Segura; Behavioral: CENSIDA counseling program
Sponsors: University of California, San Diego; University of California, San Diego; National Institute of Mental Health (NIMH)
Recruiting - verified November 2011 - Condition: HIV-1 Infection
Interventions: Drug: Isentress® (Raltegravir, 400 mg every 12 hours); Drug: Isentress® (Raltegravir, 400 every 12 hours)
Sponsors: IrsiCaixa; IrsiCaixa
Not yet recruiting - verified March 2012 - Condition: Type 2 Diabetes
Intervention: Behavioral: High Glycemic Diet
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified April 2012 - Condition: 21-hydroxylase Deficiency
Intervention: Drug: Abiraterone acetate
Sponsors: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified May 2012 - Condition: HIV-1 Infection
Interventions: Drug: Pravastatin sodium; Drug: Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate; Drug: Pravastatin sodium
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Condition: Fragile X Syndrome
Intervention: Drug: AFQ056
Sponsors: Novartis; Novartis
Not yet recruiting - verified November 2011 - Condition: HIV Infection
Intervention: Drug: antiretroviral treatment
Sponsors: Hospital Clinic of Barcelona; Hospital Clinic of Barcelona
Recruiting - verified February 2011 - Conditions: Genital Warts; HPV
Interventions: Drug: Oral Zinc; Drug: Placebo
Sponsors: University of British Columbia; University of British Columbia; British Columbia Centre for Disease Control
Not yet recruiting - verified November 2011 - Condition: Posttraumatic Stress Disorder (PTSD)
Interventions: Behavioral: Imagery Rescripting and Reprocessing Therapy; Behavioral: STAIR + Imagery Rescripting
Sponsors: VU University of Amsterdam; VU University of Amsterdam; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting - verified November 2011 - Condition: Vitamin A Deficiency
Intervention: Dietary Supplement: Vitamin A (retinyl palmitate).
Sponsors: London School of Hygiene and Tropical Medicine; London School of Hygiene and Tropical Medicine; World Health Organization
Recruiting - verified April 2012 - Condition: HIV Infections
Intervention:
Sponsors: Università Vita-Salute San Raffaele; Università Vita-Salute San Raffaele; Fondazione SanRaffaele del Monte Tabor
Not yet recruiting - verified November 2011 - Conditions: Stroke; Atrial Fibrillation
Intervention:
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: HIV Infection
Interventions: Drug: Vaccination; Drug: Placebo
Sponsors: Hospital Clinic of Barcelona; Hospital Clinic of Barcelona
Recruiting - verified April 2012 - Condition: Hepatitis C, Genotype 1
Interventions: Drug: BMS-790052 (Daclatasvir); Drug: Ribavirin; Drug: Peg-Interferon alfa 2a
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified April 2012 - Condition: HIV Infections
Interventions: Biological: Quadrivalent HPV Vaccine; Biological: Placebo Vaccine
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: Sleep Apnea, Obstructive
Intervention: Other: Divided Attention Steering Simulator (DASS)
Sponsors: Institut für Pneumologie Hagen Ambrock eV; Institut für Pneumologie Hagen Ambrock eV; Reinhard Löwenstein-Stiftung
Recruiting - verified October 2011 - Condition: Fragile X Syndrome
Interventions: Drug: Sertraline; Drug: Placebo
Sponsors: University of California, Davis; University of California, Davis
Recruiting - verified January 2012 - Condition: Metabolic Syndrome
Intervention: Other: Routine laboratory tests
Sponsors: Hillel Yaffe Medical Center; Hillel Yaffe Medical Center
Recruiting - verified November 2011 - Condition: Ovarian Cancer
Intervention:
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital
Recruiting - verified April 2011 - Conditions: Ischemic Stroke; Physical Activity
Intervention: Behavioral: Physical activity
Sponsors: Hillerod Hospital, Denmark; Hillerod Hospital, Denmark
Recruiting - verified May 2012 - Condition: HIV Infection
Interventions: Dietary Supplement: Probiotics; Dietary Supplement: Placebo
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH)
Not yet recruiting - verified November 2011 - Condition: Mild Obstructive Sleep Apnea
Interventions: Device: Continuous positive airway pressure (Resmed); Device: Oral Appliance (BRD)
Sponsors: Associacao Fundo de Incentivo a Psicofarmcologia; Associacao Fundo de Incentivo a Psicofarmcologia
Recruiting - verified October 2011 - Condition: Hepatitis C
Interventions: Drug: Telaprevir; Drug: Ribavirin; Biological: peginterferon alfa-2a
Sponsors: Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals Incorporated
Recruiting - verified May 2012 - Conditions: HIV-1-infection; Comorbidity; Ageing
Intervention:
Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Public Health Service of Amsterdam
Recruiting - verified November 2011 - Condition: Rectal Cancer
Interventions: Procedure: Abdominoperineal resection; Procedure: Intersphincteric resection
Sponsors: Seoul National University Hospital; Seoul National University Hospital; Seoul National University Bundang Hospital; National Cancer Center, Korea
Recruiting - verified November 2011 - Conditions: Temperature; Clothing; Sex; Age; Adiposity
Intervention:
Sponsors: University of Colorado, Denver; University of Colorado, Denver; University of Alabama at Birmingham
Not yet recruiting - verified November 2011 - Condition: Bacterial Vaginosis
Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol); Dietary Supplement: Placebo
Sponsors: Ohio State University; Ohio State University
Recruiting - verified October 2011 - Condition: Human Immunodeficiency Virus
Intervention: Procedure: Genital and rectal swabbing
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Condition: Human Immunodeficiency Virus
Intervention: Drug: Atripla (EFV/TDF/FTC); boosted darunavir & tenofovir/FTC; boosted atazanavir & tenofovir/FTC; raltegravir & tenofovir/FTC
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified December 2011 - Condition: Smoking Cessation
Interventions: Drug: Placebo; Drug: varenicline tartrate; Drug: bupropion hydrochloride; Drug: Nicotine Replacement Therapy Patch
Sponsors: Pfizer; Pfizer; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Amphetamine-Related Disorders
Interventions: Drug: extended-release naltrexone; Drug: Placebo
Sponsors: National Institute on Drug Abuse (NIDA); National Institute on Drug Abuse (NIDA); Alkermes
Not yet recruiting - verified October 2011 - Condition: Chronic Thrombocytopenic Purpura
Intervention: Dietary Supplement: honey
Sponsors: Ain Shams University; mamdouh abdulmaksoud abdulrhman
Not yet recruiting - verified October 2011 - Condition: Multiple Sclerosis
Intervention: Drug: Tysabri ® (Natalizumab)
Sponsors: University of South Florida; University of South Florida
Recruiting - verified October 2011 - Conditions: Colon Cancer; Rectal Cancer
Interventions: Behavioral: surveys; Behavioral: surveys; Behavioral: surveys; Behavioral: Surveys
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified March 2012 - Condition: HIV Infection
Interventions: Drug: HAART; Drug: HAART
Sponsors: Hospital Nossa Senhora da Conceicao; Hospital Nossa Senhora da Conceicao
Recruiting - verified May 2012 - Condition: Vestibulodynia
Interventions: Procedure: Multimodal physiotherapy; Drug: lidocaine
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke; Canadian Institutes of Health Research (CIHR); Fonds de la Recherche en Santé du Québec
Recruiting - verified October 2011 - Condition: Sexual Dysfunction, Physiological
Interventions: Device: Vaginal Renewal Program; Device: Vaginal Dilator
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified September 2011 - Conditions: Human Immunodeficiency Virus (HIV); HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Maraviroc
Sponsors: St Vincent's Hospital, Sydney; Bruce Brew; ViiV Healthcare
Not yet recruiting - verified October 2011 - Conditions: Renal Failure Chronic Requiring Hemodialysis; Metabolic Syndrome; Diabetes Mellitus Type 2; Hyperlipidemia
Intervention: Drug: Atorvastatin
Sponsors: Poznan University of Medical Sciences; Poznan University of Medical Sciences
Recruiting - verified October 2011 - Condition: HIV Infection
Intervention:
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH)
Recruiting - verified November 2011 - Conditions: Human Immunodeficiency Virus (HIV); HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Raltegravir
Sponsors: St Vincent's Hospital, Sydney; St Vincent's Hospital, Sydney; Merck
Not yet recruiting - verified October 2011 - Conditions: Women's Health; HIV Infection; Genital Diseases, Female
Intervention:
Sponsors: University of Colorado, Denver; University of Colorado, Denver
Recruiting - verified October 2011 - Conditions: Poverty; Orphaned Children
Interventions: Behavioral: Bridges; Behavioral: Bridges PLUS; Other: Usual Care
Sponsors: Columbia University; Columbia University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting - verified October 2011 - Conditions: Gonorrhea; Chlamydia; Trichomoniasis; Syphilis; HIV Infections
Intervention: Behavioral: Intervention
Sponsors: University of Kentucky; University of Kentucky; National Institute of Mental Health (NIMH)
Not yet recruiting - verified September 2011 - Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: dolutegravir 50 mg OAD; Drug: darunavir 800mg OAD; Drug: ritonavir 100mg OAD
Sponsors: ViiV Healthcare; ViiV Healthcare; GlaxoSmithKline
Recruiting - verified February 2012 - Conditions: HIV-1 Infection; Chronic Renal Insufficiency
Intervention: Drug: Raltegravir
Sponsors: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); Merck
Recruiting - verified April 2012 - Condition: Human Immunodeficancy Virus (HIV)
Interventions: Drug: Darunavir/Ritonavir (DRV/r); Drug: Lopinavir in fixed combination with Ritonavir; Drug: Zidovudin; Drug: Tenofovir; Drug: Efavirenz
Sponsors: Janssen-Cilag G.m.b.H; Janssen-Cilag G.m.b.H
Recruiting - verified April 2012 - Conditions: HIV Infection; Endothelial Dysfunction
Intervention: Drug: raltegravir
Sponsors: UMC Utrecht; UMC Utrecht; Merck
Recruiting - verified February 2012 - Conditions: Obstructive Sleep Apnea; Diabetes Mellitus
Intervention: Behavioral: PreDx Diabetes Risk Score
Sponsors: Mike O'Callaghan Federal Hospital; Mike O'Callaghan Federal Hospital
Recruiting - verified April 2012 - Condition: HIV-1 Infection
Intervention: Drug: Rifaximin
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Conditions: Polycystic Ovary Syndrome; Insulin Resistance
Intervention: Other: Acupuncture
Sponsors: Göteborg University; Göteborg University
Recruiting - verified October 2011 - Conditions: HIV Infections; Central Nervous System Neoplasms; Neurofibromatosis 1
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified September 2011 - Conditions: HIV Infection; Hepatitis C
Intervention: Behavioral: Contigent voucher incentive (CVI)
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Recruiting - verified October 2011 - Conditions: Prostate Cancer; Erectile Dysfunction
Interventions: Procedure: Application of a hemostatic gelatin-thrombin matrix; Procedure: Use of mono- and bipolar electrocautery and surgical clips
Sponsors: Johann Wolfgang Goethe University Hospitals; Johann Wolfgang Goethe University Hospitals
Recruiting - verified October 2011 - Conditions: Addison's Disease; Adrenal Insufficiency; Diabetes Mellitus Type I
Intervention: Procedure: Spiroergometry
Sponsors: University of Wuerzburg; University of Wuerzburg
Recruiting - verified October 2011 - Condition: Human Immunodeficiency Virus
Intervention:
Sponsors: Johann Wolfgang Goethe University Hospitals; Johann Wolfgang Goethe University Hospitals
Recruiting - verified October 2011 - Condition: Acquired Immunodeficiency Syndrome
Interventions: Drug: Dimiracetam; Drug: Dimiracetam 25 mg
Sponsors: Neurotune AG; Neurotune AG
Not yet recruiting - verified September 2011 - Conditions: Pneumococcal Infections; HIV Infections
Interventions: Biological: PPV-23 Vaccine; Biological: PCV-13 Vaccine; Biological: Placebo Vaccine
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified April 2012 - Condition: Kawasaki Disease
Intervention: Other: Cardiac evaluation
Sponsors: Hospices Civils de Lyon; Hospices Civils de Lyon
Recruiting - verified September 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate ); Drug: Antidepressant + Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified March 2012 - Conditions: Prostate Cancer; Psychosocial Effects of Cancer and Its Treatment; Radiation Toxicity; Sexual Dysfunction
Intervention: Radiation: hypofractionated radiation therapy
Sponsors: National Cancer Institute (NCI); Radiation Therapy Oncology Group; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Conditions: Human Papillomavirus; HIV-1 Infection
Intervention: Biological: Gardasil vaccine
Sponsors: Kenyatta National Hospital; Nelly R. Mugo; University of Washington; Merck
Not yet recruiting - verified October 2011 - Conditions: Adolescent Developement; Brain; Developmental Biology
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified August 2011 - Conditions: Acquired Immunodeficiency Syndrome; HIV Infections
Interventions: Drug: Cobicistat; Drug: Darunavir
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified October 2011 - Conditions: Cat-scratch Disease; Bartonella Infections
Interventions: Drug: prednison and azithromycin; Drug: prednison, azithromycin; Drug: prednison, Azenil
Sponsors: Tel-Aviv Sourasky Medical Center; Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified November 2011 - Condition: Erectile Dysfunction
Interventions: Device: Extracorporeal Shockwave Therapy Generator (Omnispec ED1000); Device: Extracorporeal Shockwave Therapy Generator (Omnispec ED1000); Device: Extracorporeal Shockwave Therapy Generator (Omnispec ED1000); Device: Extracorporeal Shockwave Therapy Generator (Omnispec ED1000)
Sponsors: Rambam Health Care Campus; Rambam Health Care Campus
Recruiting - verified January 2012 - Conditions: Human Immunodeficiency Virus Infection; Hepatitis C
Intervention:
Sponsors: G & W Laboratories Inc.; G & W Laboratories Inc.; Alquest; SMART Biotech Ltd
Recruiting - verified October 2011 - Condition: Major Depressive Disorder
Interventions: Drug: desvenlafaxine succinate sustained-release 50 mg/day; Drug: desvenlafaxine succinate sustained-release 100 mg/day; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: HIV
Intervention: Biological: Sci-B-Vac
Sponsors: Tel-Aviv Sourasky Medical Center; Tel-Aviv Sourasky Medical Center; SciGen, Israel, the vaccine manufacturer, will be providing 300 Sci-B-Vac doses
Not yet recruiting - verified October 2011 - Condition: HIV Infection
Interventions: Biological: HIV-1 Tat/delta-V2 Env combined vaccine; Biological: HIV-1 delta-V2 Env vaccine; Biological: HIV-1 Tat vaccine; Biological: HIV-1 Tat vaccine
Sponsors: Istituto Superiore di Sanita; Istituto Superiore di Sanita; Novartis Vaccines
Recruiting - verified September 2011 - Conditions: HIV-1 Infection; Cardiovascular Disease
Interventions: Other: Control; Other: Intervention Group
Sponsors: Holdsworth House Medical Practice; Holdsworth House Medical Practice
Recruiting - verified November 2011 - Condition: HIV-1-Associated Cognitive Motor Complex
Intervention:
Sponsors: Holdsworth House Medical Practice; Holdsworth House Medical Practice
Recruiting - verified November 2011 - Condition: Pelvic Organ Prolapse
Intervention:
Sponsors: Far Eastern Memorial Hospital; Far Eastern Memorial Hospital
Recruiting - verified April 2012 - Condition: HIV-1 Infection
Interventions: Dietary Supplement: Multi-strain probiotic; Dietary Supplement: Placebo; Other: Control
Sponsors: Oslo University Hospital; Oslo University Hospital; Karolinska University Hospital; TINE SA
Recruiting - verified December 2011 - Condition: Premature Ejaculation
Intervention: Drug: Clomipramine
Sponsors: Symyoo; Symyoo
Recruiting - verified September 2011 - Condition: Alcohol Abuse, Episodic Drinking Behavior
Interventions: Behavioral: Brief Motivational Intervention (BMI); Behavioral: Simple written advice
Sponsors: Rennes University Hospital; Rennes University Hospital; MAFEJ; AIRDDS-CIRDD; Observatoire Français des Drogues et des Toxicomanies (OFDT)
Recruiting - verified May 2012 - Condition: Movement Disorders
Intervention: Other: Wheelchair skills training program
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified September 2011 - Condition: HIV-1 Infection
Interventions: Drug: Coformulated EFV/FTC/TDF; Drug: Etoposide; Drug: Bleomycin and Vincristine (BV); Drug: Doxorubicin HCL Liposome Injection (PLD)
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); National Cancer Institute (NCI); National Institute of Dental and Craniofacial Research (NIDCR)
Not yet recruiting - verified September 2011 - Condition: Psoriasis
Intervention: Behavioral: Weight Loss
Sponsors: Universita di Verona; Universita di Verona
Not yet recruiting - verified September 2011 - Condition: Major Depressive Disorder
Interventions: Drug: tasimelteon; Drug: placebo
Sponsors: Vanda Pharmaceuticals; Vanda Pharmaceuticals
Recruiting - verified May 2012 - Condition: Herpes Simplex Type II
Interventions: Drug: Tenofovir; Drug: placebo gel; Drug: tenofovir disoproxil fumarate (TDF); Drug: placebo tablets
Sponsors: University of Washington; University of Washington; CONRAD; Gilead Sciences
Recruiting - verified March 2012 - Condition: Acute HIV Infection
Intervention: Other: Nucleic Acid Amplification Testing
Sponsors: University of California, San Diego; University of California, San Diego; National Institutes of Health (NIH)
Recruiting - verified September 2011 - Condition: HIV-infection/Aids
Interventions: Dietary Supplement: Vitamin D3; Dietary Supplement: Placebo
Sponsors: Children's Hospital of Philadelphia; Children's Hospital of Philadelphia; National Institutes of Health (NIH); National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified November 2011 - Conditions: HIV Infections; Acquired Immunodeficiency Syndrome
Intervention: Other: Text message
Sponsors: University of Washington; University of Washington; Kenya Medical Research Institute; University of California, San Francisco
Not yet recruiting - verified September 2011 - Conditions: HIV Infection; Tuberculosis
Intervention:
Sponsors: Lund University; Lund University; Swedish International Development Cooperation Agency (SIDA); Swedish Civil Contingencies Agency (MSB)
Recruiting - verified April 2012 - Conditions: Contraceptive Usage; Opioid Dependence
Interventions: Behavioral: Contraceptive management program; Other: Usual care
Sponsors: University of Vermont; University of Vermont
Recruiting - verified December 2011 - Condition: Hypoactive Sexual Desire Disorder
Interventions: Drug: Placebo; Drug: Sildenafil; Drug: Testosterone
Sponsors: Emotional Brain NY Inc.; Emotional Brain NY Inc.
Recruiting - verified September 2011 - Condition: HIV Infection
Intervention: Drug: Polyphenon E
Sponsors: Baylor College of Medicine; Baylor College of Medicine; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified September 2011 - Condition: HIV Prevention
Interventions: Behavioral: Integrated treatment program; Behavioral: Treatment as Usual
Sponsors: Rhode Island Hospital; Rhode Island Hospital; National Institute of Mental Health (NIMH)
Recruiting - verified August 2011 - Condition: HIV-1 Infection
Interventions: Drug: Niacin; Drug: Aspirin; Drug: Fenofibrate
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified October 2011 - Condition: Marriage, Life Event
Intervention:
Sponsors: Bezmialem Vakif University; Bezmialem Vakif University
Not yet recruiting - verified August 2011 - Conditions: HIV; Risk Reduction Behavior
Intervention: Behavioral: MILE intervention
Sponsors: University of Southern California; University of Southern California; Charles Drew University of Medicine and Science; Centers for Disease Control and Prevention
Recruiting - verified August 2011 - Condition: Atrial Fibrillation
Intervention:
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Conditions: HIV Infections; Acquired Immunodeficiency Syndrome; Disease Progression; Immune System Diseases; Malaria; Parasitic Diseases; Pneumonia; Diarrhea; Infectious Disorder of Immune System
Intervention: Other: Discontinue TMP/SMZ prophylaxis
Sponsors: University of Washington; University of Washington; Kenya Medical Research Institute
Not yet recruiting - verified August 2011 - Conditions: Immune Reconstitution Inflammatory Syndrome; Immune Reconstitution Syndrome; Tuberculosis; HIV-infection/Aids
Interventions: Drug: Dexamethasone; Drug: Atorvastatin; Drug: Naproxen; Drug: Placebo
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; Pfizer; Minnesota Medical Foundation
Not yet recruiting - verified April 2012 - Condition: Breast Cancer
Interventions: Other: questionnaire administration; Drug: fluocinonide cream; Procedure: management of therapy complications
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Female Sexual Function
Intervention:
Sponsors: Bezmialem Vakif University; Bezmialem Vakif University
Not yet recruiting - verified August 2011 - Conditions: HIV Infection; Hepatitis C
Intervention:
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Recruiting - verified August 2011 - Condition: Breast Neoplasms
Interventions: Other: Volume of Exercise; Moderate or High Volume; Other: Aerobic Exercise; Other: Aerobic Exercise
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified September 2011 - Condition: Erectile Dysfunction
Interventions: Drug: YHD1023; Drug: YHD1023; Drug: YHD1023; Drug: Cialis; Drug: Placebo
Sponsors: Yuhan Corporation; Yuhan Corporation
Recruiting - verified January 2012 - Condition: HIV Infections
Interventions: Biological: HIVAX; Biological: saline solution; Biological: HIVAX; Biological: Saline solution
Sponsors: GeneCure Biotechnologies; GeneCure Biotechnologies
Recruiting - verified September 2011 - Conditions: Polycystic Ovary Syndrome; Hyperandrogenism
Interventions: Drug: Metformin; Drug: Progesterone; Drug: estrace
Sponsors: University of Virginia; University of Virginia; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2011 - Conditions: Polycystic Ovary Syndrome; Hyperandrogenism
Interventions: Drug: Progesterone; Drug: Placebo
Sponsors: University of Virginia; University of Virginia; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2011 - Conditions: Cervical Cancer; Chemotherapeutic Agent Toxicity; Cognitive/Functional Effects; Psychosocial Effects of Cancer and Its Treatment; Radiation Toxicity; Sexuality and Reproductive Issues
Interventions: Drug: carboplatin; Drug: cisplatin; Drug: paclitaxel
Sponsors: National Cancer Institute (NCI); Gynecologic Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Polycystic Ovary Syndrome; Hyperandrogenism
Interventions: Drug: Flutamide; Drug: Progesterone; Drug: estrace (estradiol)
Sponsors: University of Virginia; University of Virginia; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified September 2011 - Conditions: Ejaculatory Dysfunction; Hypogonadism
Interventions: Drug: Testosterone Solution 2%; Drug: Placebo Solution
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Obesity; Cardiovascular Diseases
Intervention: Other: Didactic Concerts
Sponsors: Agencia Lain Entralgo; Agencia Lain Entralgo; Gerencia de Atención Primaria, Madrid; Hospital Universitario de la Princesa; Instituto de Salud Carlos III; MINISTERIO DE SANIDAD, POLITICA SOCIAL E IGUALDAD.ESPAÑA; CONSEJERIA DE EDUCACIÓN. COMUNIDAD DE MADRID
Not yet recruiting - verified August 2011 - Conditions: Hot Flashes; Menopause; Vasomotor Disturbance
Interventions: Drug: Low-dose 17-ß-estradiol; Drug: Venlafaxine XR; Drug: Placebo
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center; National Institute on Aging (NIA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Complementary and Alternative Medicine (NCCAM); Office of Research on Women's Health (ORWH)
Recruiting - verified December 2011 - Conditions: Idiopathic Growth Hormone Deficiency; Turner Syndrome
Intervention: Other: Blood sampling
Sponsors: Merck KGaA; Merck KGaA; Merck Serono S.A., Geneva
Recruiting - verified May 2012 - Conditions: Human Immunodeficiency Virus; Lipohypertrophy
Intervention: Drug: Raltegravir-Maraviroc
Sponsors: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); Merck; ViiV Healthcare
Recruiting - verified April 2012 - Condition: HIV-Infection
Intervention: Other: Time of starting antiretroviral therapy
Sponsors: Universitätsklinikum Hamburg-Eppendorf; Universitätsklinikum Hamburg-Eppendorf
Not yet recruiting - verified August 2011 - Conditions: Polycystic Ovary Syndrome; Obesity; Hyperandrogenism
Interventions: Drug: Dexamethasone; Drug: r-hCG (Ovidrel)
Sponsors: University of Virginia; University of Virginia; University of California, San Diego
Recruiting - verified August 2011 - Conditions: HIV; AIDS; Peripheral Neuropathy; Pain; Sleep
Interventions: Device: Splinting application to the lower extremities; Device: Splint liner application
Sponsors: Texas Woman's University; Texas Woman's University; Harris County Hospital District; DJO Incorporated
Recruiting - verified March 2012 - Condition: Rectal Cancer
Interventions: Procedure: robot-assisted surgery; Procedure: Laparoscopic surgery
Sponsors: Kyungpook National University; Kyungpook National University
Recruiting - verified November 2011 - Conditions: Chronic Kidney Disease; Renal Insufficiency
Intervention:
Sponsors: University of California, Los Angeles; University of California, Los Angeles; Gentian
Not yet recruiting - verified July 2011 - Condition: HIV Infection
Intervention: Biological: blood sampling
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis
Not yet recruiting - verified January 2012 - Conditions: Streptococcal Infections; Gram-Positive Bacterial Infections; Bacterial Infections
Intervention: Biological: Group B streptococcus vaccine
Sponsors: Novartis; Novartis Vaccines
Recruiting - verified May 2012 - Conditions: HIV; Sexually Transmitted Infections
Interventions: Behavioral: Connect 'n Unite; Behavioral: Wellness Promotion
Sponsors: Columbia University; Columbia University; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified January 2012 - Condition: The Focus of the Study is the Treatment and Retention in Treatment for HIV+ ex Inmates.
Intervention: Behavioral: Peer Navigator
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Not yet recruiting - verified July 2011 - Condition: Correct and Consistent Condom Use.
Intervention: Behavioral: Homework Intervention Strategy
Sponsors: Indiana University; Indiana University
Recruiting - verified February 2012 - Conditions: Sexual Risk Behavior; Childhood Sexual Abuse; Stress Disorders, Post-Traumatic
Interventions: Behavioral: Cognitive Processing Therapy for Sexual Risk; Behavioral: Supportive Psychotherapy; Behavioral: Sexual Risk Reduction Intervention
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Fenway Community Health; University of Miami
Recruiting - verified March 2012 - Condition: HIV-1 Infection
Interventions: Drug: Atripla; Drug: Calcium Carbonate; Drug: Vitamin D3; Drug: Placebo for calcium carbonate; Drug: Placebo for vitamin D3
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: Endometriosis
Intervention: Other: Questionnaires
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified February 2012 - Condition: HIV-infection
Intervention: Drug: Angiotensin II Infusion
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified February 2012 - Conditions: HIV Infection; Tuberculosis
Interventions: Drug: Experimental: Empiric TB treatment; Drug: ART only arm
Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); European and Developing Countries Clinical Trials Partnership (EDCTP)
Not yet recruiting - verified March 2011 - Conditions: Tuberculosis; HIV Infections
Interventions: Drug: Rifapentine (RPT); Drug: Isoniazid (INH); Dietary Supplement: Pyridoxine (Vitamin B6)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified May 2012 - Conditions: Hepato/Renal Fibrocystic Disease; Autosomal Recessive Polycystic Kidney Disease; Joubert Syndrome; Bardet Biedl Syndrome; Meckel-Gruber Syndrome; Congenital Hepatic Fibrosis; Caroli Syndrome; Oro-Facial-Digital Syndrome Type I; Nephronophithisis; Glomerulocystic Kidney Disease
Intervention:
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified September 2011 - Condition: Acquired Immunodeficiency Syndrome
Intervention:
Sponsors: Stanford University; Stanford University
Recruiting - verified July 2011 - Condition: HIV-1 Infection
Interventions: Drug: Darunavir; Drug: Ritonavir; Drug: Tenofovir disoproxil fumarate; Drug: Emtricitabine; Drug: Placebo for Tenofovir disoproxil fumarate; Drug: Placebo for Maraviroc
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified September 2011 - Conditions: Uterine Prolapse; Stage III
Interventions: Procedure: Procedure: TVH and GYNECARE PROSIMA* Pelvic Floor Repair System; Procedure: Procedure: TVH and Modified Pelvic Floor Reconstruction Surgery with mesh
Sponsors: Peking Union Medical College Hospital; Peking Union Medical College Hospital
Recruiting - verified March 2011 - Condition: Narcolepsy
Intervention: Other: No intervention
Sponsors: Hopital du Sacre-Coeur de Montreal; Hopital du Sacre-Coeur de Montreal; GlaxoSmithKline
Recruiting - verified July 2011 - Condition: Obesity
Intervention: Procedure: Transvaginal NOTES sleeve gastrectomy
Sponsors: University of California, San Diego; University of California, San Diego
Recruiting - verified July 2011 - Condition: Opiate Dependence
Interventions: Drug: Vivitrol; Drug: Naltrexone (oral); Behavioral: BDRC; Behavioral: Medical Management
Sponsors: Yale University; Yale University; St. Petersburg State Pavlov Medical University; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified July 2011 - Condition: Hepatitis C, Chronic
Interventions: Drug: BI201335; Drug: BI201335 24W; Drug: PegIFN/RBV; Drug: PegIFN/RBV
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Coronary Acute Syndrome
Intervention:
Sponsors: French Cardiology Society; French Cardiology Society
Recruiting - verified June 2011 - Condition: HIV-infection
Intervention: Procedure: Colon biopsy
Sponsors: South East Asia Research Collaboration with Hawaii; South East Asia Research Collaboration with Hawaii; Armed Forces Research Institute of Medical Sciences, Thailand; Thai Red Cross AIDS Research Centre
Recruiting - verified July 2011 - Conditions: Chronic Abacterial Prostatitis; Chronic Pelvic Pain Syndrome
Interventions: Drug: ASP3652; Drug: Placebo
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc
Recruiting - verified November 2011 - Conditions: Pelvic Organ Prolapse; Stage II-III
Intervention: Procedure: Procedure: GYNECARE PROSIMA* Pelvic Floor Repair System
Sponsors: Peking Union Medical College Hospital; Peking Union Medical College Hospital
Recruiting - verified July 2011 - Conditions: Drug Use; HIV; Hepatitis C
Intervention: Behavioral: Brief motivational intervention
Sponsors: Rhode Island Hospital; Rhode Island Hospital; National Institute on Drug Abuse (NIDA)
Recruiting - verified July 2011 - Conditions: Depression; Anxiety; PTSD
Interventions: Behavioral: Treatment as usual; Behavioral: Voluntary Savings/Loans Assoc; Behavioral: Cognitive Processing Therapy
Sponsors: Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Bloomberg School of Public Health
Recruiting - verified June 2011 - Condition: HIV Infection
Intervention: Biological: blood and semen sampling, specific biological exams and biobank and self administered questionnaires
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - verified August 2011 - Condition: Breast Cancer
Intervention: Behavioral: questionnaire
Sponsors: University of Southern Denmark; University of Southern Denmark; Danish Cancer Society; University Medical Centre Groningen; Rigshospitalet, Copenhagen University; University Hospital Herlev
Recruiting - verified February 2012 - Conditions: Diabetes Mellitus, Type 2; Erectile Dysfunction
Interventions: Drug: Insulin; Drug: Insulin
Sponsors: Jothydev's Diabetes and Research Centre; Jothydev's Diabetes and Research Centre
Recruiting - verified February 2012 - Condition: HIV Infected
Intervention: Drug: Tenofovir, Emtricitabine, Atazanavir, Ritonavir
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Conditions: HIV; Drug Addiction
Interventions: Behavioral: Psycho-education; Behavioral: Experimental
Sponsors: RTI International; RTI International; University of Cape Town
Recruiting - verified December 2011 - Conditions: HIV Negative; Adaptive Immunity; Innate Immunity
Interventions: Biological: VRC-HIVDNA016-00-VP; Biological: VRC-HIVADV014-00-VP
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified June 2011 - Conditions: Anogenital Warts; HIV
Intervention:
Sponsors: University of California, Los Angeles; University of California, Los Angeles; Espacio Comun; Universidad Peruana Cayetano Heredia
Recruiting - verified April 2012 - Condition: Inguinal Hernia
Intervention: Procedure: Isolation of the spermatic cord from mesh
Sponsors: Chatham Kent Health Alliance; Chatham Kent Health Alliance
Recruiting - verified July 2011 - Conditions: Type 2 Diabetes; Impaired Glucose Tolerance; Obesity; Physical Activity
Intervention: Behavioral: Lifestyle intervention
Sponsors: Region Skane; Region Skane
Recruiting - verified August 2011 - Condition: HIV Infection
Intervention:
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb; PENTA Foundation
Recruiting - verified March 2012 - Condition: HIV Prevention
Interventions: Drug: Tenofovir gel; Drug: Universal placebo gel
Sponsors: CONRAD; CONRAD; Follow-on African Consortium for Tenofovir Studies (FACTS); United States Agency for International Development (USAID)
Recruiting - verified May 2012 - Condition: Overweight
Intervention: Behavioral: Lifestyle counseling
Sponsors: Halmstad University; Halmstad University; Carema; Region Halland
Recruiting - verified March 2011 - Conditions: Male Infertility; Leukopenia; Postinfection Inflammation; Oxidative Stress
Interventions: Drug: Prednisone; Drug: Placebo
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified August 2011 - Condition: Prostate Cancer
Interventions: Device: Artificial urinary sphincter; Device: InVance Sling; Device: AdVance Sling; Device: Virtue Sling; Drug: Contigen
Sponsors: Stanford University; Stanford University
Recruiting - verified February 2012 - Conditions: Tennis Elbow; Epicondylitis, Lateral Humeral
Interventions: Procedure: Ultrasound of the elbow 1, days 7 to 15; Procedure: Ultrasound of the elbow 2, days 7 to 15; Procedure: Ultrasound of the elbow 3, days 45 to 90
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified September 2011 - Conditions: HIV Seronegativity; HIV Preventive Vaccine
Interventions: Biological: MVA-C + gp140/MF59; Biological: MVA-C + gp140/MF59; Biological: DNA-C2 + MVA-C; Biological: DNA-C2 + MVA-C + gp140/MF59
Sponsors: HIV Vaccine Trials Network; HIV Vaccine Trials Network; South Africa AIDS Vaccine Initiative
Recruiting - verified November 2011 - Conditions: Estradiol Receptor Polymorphism; Progesterone Receptor Polymorphism; IVF; Subfertility
Intervention:
Sponsors: Infertility Treatment Center Dortmund; Infertility Treatment Center Dortmund; Weill Medical College of Cornell University
Recruiting - verified June 2011 - Condition: PostTraumatic Stress Disorder
Intervention: Procedure: MRI-based techniques (sMRI, fMRI, DTI, ASL)
Sponsors: University Hospital, Tours; University Hospital, Tours
Recruiting - verified November 2010 - Condition: Sexually Active
Intervention: Other: Text Message
Sponsors: Boston Medical Center; Boston Medical Center
Recruiting - verified June 2011 - Condition: Preeclampsia
Intervention:
Sponsors: Saint Thomas Hospital, Panama; Saint Thomas Hospital, Panama
Not yet recruiting - verified January 2012 - Condition: Cancer
Interventions: Drug: prasterone; Other: placebo
Sponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Condition: Prostate Cancer
Interventions: Device: RapidStrand seeds for use with 18g needle; Device: ThinStrand
Sponsors: Prostate Cancer Foundation of Chicago; Prostate Cancer Foundation of Chicago
Recruiting - verified June 2011 - Condition: HIV Infection
Interventions: Drug: Atripla (r); Drug: Efavirenz; Drug: Truvada; Drug: Rifampin/isoniazid/pyrazinamide/ethambutol FDC; Drug: Rifampin/isoniazid FDC
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Conditions: Turner Syndrome; Ovarian Insufficiency
Intervention: Procedure: Ovariectomy
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Groupe Hospitalier Pitie-Salpetriere; Cochin Hospital
Recruiting - verified July 2011 - Condition: Human Volunteers
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Conditions: Impulsive Behavior; Substance Abuse; HIV Risk Behavior; Anxiety; Depression; Criminogenic Thinking
Interventions: Behavioral: REVAMP; Behavioral: TAU
Sponsors: George Mason University; George Mason University
Recruiting - verified June 2011 - Conditions: Human Immunodeficiency Virus; Acquired Immunodeficiency Syndrome; Opiate Addiction; Drug Dependence
Intervention: Drug: Buprenorphine/naloxone
Sponsors: Yale University; Yale University; George Mason University; Howard University
Recruiting - verified April 2012 - Condition: Major Depressive Disorder
Intervention: Drug: LY2216684
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified February 2012 - Condition: Treatment Outcome
Interventions: Drug: Lu AA21004; Drug: Escitalopram
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified May 2012 - Condition: Human Immunodeficiency Virus-1
Interventions: Drug: BMS-663068; Drug: BMS-663068; Drug: BMS-663068; Drug: BMS-663068; Drug: Raltegravir; Drug: Raltegravir; Drug: Tenofovir; Drug: Tenofovir; Drug: Ritonavir; Drug: Atazanavir
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified February 2012 - Conditions: Substance Abuse; HIV Risk; Shame; Guilt; Empathy; Criminogenic Thinking
Interventions: Behavioral: Impact of Crime Modules; Behavioral: TAU
Sponsors: George Mason University; George Mason University; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified June 2011 - Conditions: Substance Abuse; HIV Risk; Criminogenic Thinking; Shame; Guilt; Empathy
Interventions: Behavioral: MI plus IOC group intervention; Behavioral: Motivational Interview only
Sponsors: George Mason University; George Mason University; National Institute on Drug Abuse (NIDA)
Recruiting - verified June 2011 - Condition: Pelvic Organ Prolapse
Intervention: Device: Restorelle Direct Fix A&P
Sponsors: Coloplast A/S; Coloplast A/S
Recruiting - verified March 2012 - Condition: Cancer
Interventions: Radiation: First part of treatment : Conformal irradiation; Procedure: Fiducials placement; Radiation: Second part : hypofractionated stereotactic boost
Sponsors: Centre Oscar Lambret; Centre Oscar Lambret
Recruiting - verified May 2012 - Conditions: HIV Infection; Substance Abuse
Interventions: Behavioral: Trans-theoretical Process of Change Model-self; Behavioral: Trans-theoretical Process of Change Model - interviewer
Sponsors: Nova Southeastern University; Nova Southeastern University; National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2012 - Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected WomenConditions: Human Immunodeficiency Virus (HIV); Self-efficacy; Self-esteem
Intervention: Behavioral: Ipod video
Sponsors: Duke University; Duke University; National Institute of Nursing Research (NINR)
Not yet recruiting - verified July 2011 - Condition: Ischemic Attack, Transient
Intervention: Other: Physical activation on Prescription
Sponsors: Tiohundra AB; Tiohundra AB; Karolinska Institutet
Recruiting - verified January 2012 - Condition: Premature Ejaculation
Intervention: Drug: dapoxetine
Sponsors: Yuhan Corporation; Yuhan Corporation
Recruiting - verified August 2011 - Condition: HIV
Intervention: Behavioral: Peer Health Worker
Sponsors: Johns Hopkins University; Johns Hopkins University
Recruiting - verified March 2012 - Condition: Depression With Prominent Agitation
Interventions: Drug: Quetiapine XR; Drug: Escitalopram
Sponsors: Physicians Research And Education Network; Physicians Research And Education Network
Recruiting - verified May 2011 - Conditions: Human Immunodeficiency Virus (HIV) Infections; Acquired Immunodeficiency Syndrome (AIDS) Virus
Interventions: Drug: Darunavir; Drug: Ritonavir
Sponsors: Janssen-Cilag International NV; Janssen-Cilag International NV
Recruiting - verified May 2012 - Condition: Falciparum Malaria
Intervention: Drug: Primaquine
Sponsors: London School of Hygiene and Tropical Medicine; London School of Hygiene and Tropical Medicine; Wellcome Trust
Recruiting - verified January 2012 - Condition: HIV Positive
Intervention: Drug: Vorinostat
Sponsors: Bayside Health; Bayside Health; Merck
Recruiting - verified June 2011 - Conditions: Nonfatal Myocardial Infarction; Coronary Death
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Not yet recruiting - verified May 2011 - Condition: HIV Infections
Interventions: Drug: Dapivirine Vaginal Ring; Drug: Maraviroc Vaginal Ring; Other: Placebo Vaginal Ring; Drug: Dapivirine-Maraviroc Vaginal Ring
Sponsors: International Partnership for Microbicides, Inc.; International Partnership for Microbicides, Inc.
Recruiting - verified November 2011 - Conditions: Chronic Renal Insufficiency; Acute Renal Failure
Intervention:
Sponsors: Medical University of Graz; Vanessa Stadlbauer-Koellner, MD; Austrian Science Foundation
Recruiting - verified April 2012 - Condition: Turner Syndrome
Intervention: Drug: somatotropin
Sponsors: University of North Carolina, Chapel Hill; Marsha Davenport, MD; Pfizer
Recruiting - verified January 2012 - Condition: HIV Infection
Interventions: Drug: Maraviroc, Darunavir/r; Drug: current antiretroviral therapy with 3 drugs
Sponsors: Catholic University of the Sacred Heart; Catholic University of the Sacred Heart
Recruiting - verified June 2011 - Conditions: Nonfatal Myocardial Infarction; Coronary Death
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified June 2011 - Condition: Thrombosis
Intervention: Other: No intervention
Sponsors: University Hospital, Basel, Switzerland; University Hospital, Basel, Switzerland
Recruiting - verified June 2011 - Conditions: Healthy; Dystonia; Parkinson Disease
Interventions: Device: Tracking eye movement; Device: Tracking eye movement under deep brain stimulation
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified December 2011 - Condition: Polycystic Ovary Syndrome
Intervention: Drug: folate-boosted 3 mg DRSP/20 μg EE-24/4 oral contraceptive
Sponsors: BC Women's Hospital & Health Centre; BC Women's Hospital & Health Centre; Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
Recruiting - verified March 2012 - Condition: Opiate Dependence
Interventions: Behavioral: Behavioral Drug and HIV Risk Reduction Counseling; Behavioral: Educational Counseling; Behavioral: Treatment as Usual
Sponsors: Yale University; Yale University; Centers for Disease Control and Prevention, China
Recruiting - verified July 2011 - Conditions: Hepatitis; HIV; Liver Cancer
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institutes of Health Clinical Center (CC); Washington DC Veterans Affairs Medical Center
Recruiting - verified February 2012 - Condition: Erectile Dysfunction
Interventions: Drug: Sildenafil 100 mg; Drug: Tadalafil 20 mg; Drug: Combination half of maximal dose for sildenafil & tadalafil
Sponsors: Rambam Health Care Campus; Rambam Health Care Campus
Not yet recruiting - verified April 2011 - Conditions: Alcohol Consumption; Unsafe Sex
Interventions: Behavioral: Brief Motivational Intervention (BMI); Behavioral: Brief Advice
Sponsors: Brown University; Brown University; National Institute on Alcohol Abuse and Alcoholism (NIAAA); Memorial Hospital of Rhode Island; Kent Hospital
Recruiting - verified November 2011 - Conditions: Autism Spectrum Disorders; Psychosis; Fragile X Syndrome
Intervention:
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill
Recruiting - verified March 2012 - Condition: Fragile X Syndrome
Interventions: Drug: AFQ056; Drug: AFQ056; Drug: AFQ056; Drug: Placebo
Sponsors: Novartis; Novartis
Recruiting - verified May 2012 - Condition: Human Immunodeficiency Virus (HIV) Infection
Intervention: Drug: Etravirine
Sponsors: Janssen R&D Ireland; Janssen R&D Ireland
Recruiting - verified April 2012 - Conditions: Acquired Immunodeficiency Syndrome; HIV Infections
Interventions: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir DF; Drug: cobicistat and atazanavir or cobicistat and darunavir
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified March 2012 - Condition: Epilepsy, Partial
Intervention: Drug: Lacosamide
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Early Inflammatory Arthritis
Interventions: Behavioral: One-on-one peer support; Behavioral: Standard of care
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre; Canadian Rheumatology Association; Mount Sinai Hospital, Toronto, Canada; The Arthritis Society, Canada; St. Michael's Hospital, Toronto; University of Toronto
Recruiting - verified December 2011 - Conditions: HIV-1 Infection; AIDS
Interventions: Drug: Maraviroc (Celsentri); Drug: Placebo
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis; Pfizer
Recruiting - verified December 2011 - Condition: HIV Infection
Interventions: Drug: atazanavir; Drug: atazanavir/ritonavir
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified September 2011 - Condition: Fragile X Syndrome
Intervention: Drug: AFQ056
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: HIV
Intervention: Behavioral: Treatment Advocacy
Sponsors: Children's Hospital Boston; Children's Hospital Boston; National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Condition: HIV Infections
Intervention: Drug: "Kallunk oxide (Immunotherapy) "
Sponsors: Traditional Alternative Medicine Research, India; Traditional Alternative Medicine Research, India
Recruiting - verified May 2012 - Conditions: HIV Infections; Central Nervous System Diseases; Dementia
Interventions: Drug: zidovudine-lamivudine-nevirapine; Drug: tenofovir-lamivudine-efavirenz
Sponsors: University of California, San Diego; University of California, San Diego; National Institute of Mental Health (NIMH); National Center for AIDS/STD Control and Prevention, China CDC; Beijing YouAn Hospital; Beijing Ditan Hospital
Recruiting - verified January 2012 - Conditions: Neurocognitive Disturbance; HIV Infection
Interventions: Drug: Lithium; Drug: Rivastigmine; Behavioral: not initiate treatment
Sponsors: Fundacio Lluita Contra la SIDA; Fundacio Lluita Contra la SIDA
Recruiting - verified April 2012 - Condition: HIV Infection
Intervention:
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital
Recruiting - verified November 2011 - Condition: HIV Disease
Interventions: Drug: HAART regimen; Drug: 3TC or FTC monotherapy
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2012 - Condition: HIV-1 Infection
Interventions: Drug: Cenicriviroc 100 mg; Drug: Cenicriviroc 200 mg + Truvada; Drug: Sustiva + Truvada
Sponsors: Tobira Therapeutics, Inc.; Tobira Therapeutics, Inc.
Recruiting - verified October 2011 - Condition: Metastatic Kidney Cancer
Intervention:
Sponsors: Centre Francois Baclesse; Centre Francois Baclesse; Hoffmann-La Roche
Recruiting - verified April 2011 - Condition: Psoriasis
Intervention:
Sponsors: Abbott; Abbott; pH Associates
Recruiting - verified February 2012 - Condition: HIV Infection
Intervention: Behavioral: Positive STEPS
Sponsors: Fenway Community Health; Fenway Community Health; Children's Hospital Boston; Massachusetts General Hospital; Harvard University
Recruiting - verified April 2011 - Condition: HIV
Interventions: Drug: Atazanavir Sulphate; Drug: Ritonavir
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified April 2012 - Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infectionCondition: Human Immunodeficiency Virus Infection
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: HIV/AIDS
Interventions: Behavioral: Family-Based HIV prevention; Other: Adolescent Only Health Promotion
Sponsors: Rhode Island Hospital; Rhode Island Hospital
Recruiting - verified July 2011 - Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: dolutegravir
Sponsors: ViiV Healthcare; ViiV Healthcare; Shionogi; GlaxoSmithKline
Recruiting - verified February 2012 - Condition: HIV Infection
Intervention: Behavioral: Community Mobilization
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH)
Recruiting - verified October 2011 - Conditions: Marfan Syndrome; Turner Syndrome; Ehlers-Danlos Syndrome; Loeys-Dietz Syndrome; FBN1, TGFBR1, TGFBR2, ACTA2 or MYH11 Genetic Mutation; Bicuspid Aortic Valve Without Known Family History; Bicuspid Aortic Valve With Family History; Bicuspid Aortic Valve With Coarctation; Familial Thoracic Aortic Aneurysm and Dissections; Shprintzen-Goldberg Syndrome; Other Aneurysms and Dissections of the Thoracic Aorta Not Due to Trauma, <50yo; Other Congenital Heart Disease
Intervention:
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified May 2012 - Condition: Acquired Immunodeficiency Syndrome
Intervention:
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified October 2011 - Conditions: Painful Bladder Syndrome; Interstitial Cystitis; Pelvic Floor; Insufficiency; Bowel Dysfunction; Sexual Dysfunction; Pelvic Floor; Incompetency
Intervention: Other: Changing the Interstim parameter '' Frequency"
Sponsors: Pelvic and Sexual Health Institute; Pelvic and Sexual Health Institute
Recruiting - verified December 2011 - Condition: Fragile X Syndrome
Interventions: Drug: arbaclofen; Drug: arbaclofen; Drug: arbaclofen; Drug: Placebo
Sponsors: Seaside Therapeutics, Inc.; Seaside Therapeutics, Inc.
Recruiting - verified March 2012 - Conditions: HIV; Hepatitis C; Syphilis; Herpes Simplex Type II
Interventions: Behavioral: MMT provider dosage training; Behavioral: targeted counseling; Other: national guidelines
Sponsors: Centers for Disease Control and Prevention; Centers for Disease Control and Prevention; National Center for AIDS/STD Control and Prevention, China CDC
Recruiting - verified April 2012 - Osteopathic Manipulation for Female Interstitial Cystitis Patients With Sacroiliac Joint DysfunctionConditions: Interstitial Cystitis; Sacroiliac Joint Dysfunction
Intervention: Procedure: Osteopathic Manipulation Therapy
Sponsors: Pelvic and Sexual Health Institute; Pelvic and Sexual Health Institute; Interstitial Cystitis Association
Recruiting - verified December 2011 - Conditions: Vulvovaginal Atrophy; Dyspareunia Among Puerperal Women
Intervention: Drug: Estriol 0.1% vaginal cream
Sponsors: Meir Medical Center; Meir Medical Center
Recruiting - verified April 2012 - Condition: Polycystic Ovary Syndrome
Intervention: Other: Weight reduction regimen
Sponsors: Göteborg University; Göteborg University
Recruiting - verified October 2011 - Condition: Breast Cancer
Intervention: Other: Weight Loss Dietary Pattern
Sponsors: Colorado State University; Colorado State University
Recruiting - verified February 2012 - The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ARTCondition: HIV-1 Infection
Intervention: Drug: Vorinostat
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Institutes of Health (NIH); Merck; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Condition: HIV-1 Infection
Interventions: Procedure: cervical cryotherapy; Procedure: Loop Electrosurgical Excision Procedure (LEEP)
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2012 - Conditions: HIV; Depression; Drug Use
Interventions: Behavioral: Workshop; Behavioral: Workshop control
Sponsors: Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Bloomberg School of Public Health; National Institute on Drug Abuse (NIDA)
Recruiting - verified June 2011 - Condition: Behavioral Disorders Due to Psychoactive Substance Use
Interventions: Behavioral: HealthCall and Motivational Interviewing; Behavioral: Motivational Interviewing (MI); Behavioral: HIV/AIDS health education
Sponsors: Research Foundation for Mental Hygiene; Research Foundation for Mental Hygiene
Recruiting - verified March 2010 - Condition: Depression
Intervention:
Sponsors: Hallym University Medical Center; Hallym University Medical Center; Bundang CHA Hospital; Myongji Hospital
Recruiting - verified March 2011 - Condition: Premature Pubarche
Interventions: Drug: sugar pill; Drug: Metformin, glucophage
Sponsors: Penn State University; Penn State University
Not yet recruiting - verified September 2011 - Conditions: HIV; Medication Adherence; Substance Dependence
Intervention: Behavioral: Spiritual Self-Schema Therapy
Sponsors: Hunter College; Hunter College; Fordham University
Recruiting - verified February 2011 - Conditions: HIV; Hepatitis C; Hepatitis B; Syphilis
Interventions: Device: Rapid tests for HIV, HCV, HBV, and syphilis; Device: HIV/HCV; Device: HIV/syphilis; Device: HIV only
Sponsors: California State University, Long Beach; California State University, Long Beach; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Conditions: Adrenal Hyperplasia; Polycystic Ovarian Syndrome; Oligomenorrhea; Obesity; Hyperandrogenism
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified January 2012 - Condition: Human Immunodeficiency Virus
Interventions: Behavioral: RBT; Other: Case-Management
Sponsors: RTI International; RTI International; National Institute on Drug Abuse (NIDA)
Recruiting - verified December 2011 - Conditions: HIV Infection; Cardiovascular Disease; Inflammation
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco; GlaxoSmithKline
Recruiting - verified November 2011 - Condition: Male Infertility
Interventions: Drug: Cholecalciferol and calcium; Other: Placebo
Sponsors: Rigshospitalet, Denmark; Rigshospitalet, Denmark
Recruiting - verified February 2011 - Conditions: Oropharyngeal Cancer; Human Papillomavirus
Intervention:
Sponsors: Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Bloomberg School of Public Health; Mount Sinai School of Medicine; Oregon Health and Science University; Dana-Farber Cancer Institute; Johns Hopkins Hospital (JHH)
Recruiting - verified May 2012 - Conditions: HIV-1 Infection; Kaposi's Sarcoma
Interventions: Drug: efavirenz/emtricitabine/tenofovir disoproxil fumarate; Drug: etoposide
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Condition: Erectile Dysfunction
Interventions: Device: Omnispec model ED1000; Device: Sham control
Sponsors: Rambam Health Care Campus; Rambam Health Care Campus
Recruiting - verified March 2011 - Conditions: HIV Infection; AIDS
Interventions: Other: Standard Care; Other: Virological Monitoring
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center; Bach Mai Hospital; Roche Molecular Systems, Inc
Recruiting - verified January 2012 - Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Placebo; Drug: Rotigotine
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: LY2216684; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Breast Cancer; Lung Cancer
Interventions: Biological: Breast cancer cohort; Biological: Lung cancer cohort
Sponsors: Centre Leon Berard; Centre Leon Berard; UBET (Biostatistic and Therapeutic Evaluation Unit); BEC (Department of Clinical Sciences)
Recruiting - verified May 2012 - Conditions: A/H1N1 Influenza; Swine Flu
Intervention:
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital; American University of Beirut Medical Center
Recruiting - verified May 2012 - Condition: HIV Infection
Interventions: Drug: Ritonavir boosted Atazanavir + Lamivudine; Drug: Ritonavir boosted Atazanavir + 2 NRTIs
Sponsors: Fundacion SEIMC-GESIDA; Fundacion SEIMC-GESIDA; Bristol-Myers Squibb
Recruiting - verified February 2012 - Conditions: Vestibulodynia; Vulvodynia
Intervention: Drug: Milnacipran
Sponsors: University of Tennessee; University of Tennessee; Forest Laboratories
Recruiting - verified November 2011 - Condition: Gender Identity Disorder
Intervention: Drug: Hormones
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified November 2011 - Conditions: Varicocele; Infertility; Semen Quality
Intervention: Procedure: Hormone and semen measurements before varicocelectomy
Sponsors: Copenhagen University Hospital at Herlev; Copenhagen University Hospital at Herlev; Rigshospitalet, Denmark
Recruiting - verified February 2012 - Conditions: Chlamydia Infection; Gonococcal Infection; Sexually Transmitted Diseases
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco; Abbott Molecular
Not yet recruiting - verified April 2012 - Condition: HIV Infections
Interventions: Drug: GSK1349572 tablet formulation; Drug: GSK1349572 pediatric formulation
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: Meningococcal Disease
Intervention:
Sponsors: London School of Hygiene and Tropical Medicine; London School of Hygiene and Tropical Medicine; Bill and Melinda Gates Foundation
Recruiting - verified April 2012 - Conditions: Non-small Cell Lung Cancer; Hiv-positive
Intervention: Drug: Chemotherapy
Sponsors: Intergroupe Francophone de Cancerologie Thoracique; Intergroupe Francophone de Cancerologie Thoracique
Recruiting - verified March 2012 - Condition: HIV-1 Infection
Intervention: Drug: depo-medroxyprogesterone acetate
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2011 - Condition: Cancer
Interventions: Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: assessment of therapy complications; Procedure: fertility assessment and management; Procedure: psychosocial assessment and care; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Institut Catala D'Oncologia
Recruiting - verified February 2011 - Condition: HIV Infection
Intervention: Drug: Interferon Alpha 2b
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2011 - Conditions: HIV Infection; Yellow Fever
Interventions: Biological: Yellow fever vaccination (STAMARIL); Biological: Placebo
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - verified January 2012 - Condition: HIV Infections
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Conditions: HIV; Sexually Transmitted Diseases
Interventions: Behavioral: Hombre Seguro; Behavioral: Didactic attention-control condition
Sponsors: University of California, San Diego; University of California, San Diego
Recruiting - verified November 2011 - Condition: HIV-associated Co-morbidities
Interventions: Dietary Supplement: conventional vitamin D treatment versus a tiered/titrated dosing strategy; Drug: tiered/titrated vitamin D treatment
Sponsors: Mount Sinai School of Medicine; Andrea D. Branch; National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2012 - Condition: HIV Infection
Intervention: Drug: Lopinavir/ritonavir (LPV/r)
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Abbott
Recruiting - verified May 2012 - Conditions: HIV; Sexually Transmitted Diseases
Intervention: Behavioral: It's Your Game Tech
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston; National Institute of Mental Health (NIMH)
Recruiting - verified March 2012 - Condition: AIDS
Interventions: Behavioral: FAmily CEntered (FACE) ACP; Behavioral: Healthy Living Control
Sponsors: Children's Research Institute; Children's Research Institute; St. Jude Children's Research Hospital; Johns Hopkins University; University of Miami
Recruiting - verified February 2012 - Condition: Lower Urinary Tract Symptoms
Intervention: Drug: Tolterodine SR
Sponsors: Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Science Council, Taiwan
Recruiting - verified September 2011 - Condition: HIV Infection Associated Kaposi Disease
Intervention: Drug: Lenalidomide
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis; Celgene Corporation
Recruiting - verified June 2011 - Condition: HIV Infection
Intervention: Device: Acoustic radiation force impulse imaging
Sponsors: Yonsei University; Yonsei University; Severance Hospital
Recruiting - verified February 2012 - Conditions: Hypogonadotropic Hypogonadism; Kallmann Syndrome
Interventions: Drug: Tranditional intervention for HH using HCG and FSH; Drug: Sequential intervention for HH using HCG and FSH; Drug: Sequential intervention for HH using HCG and FSH plus zinc
Sponsors: Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University School of Medicine
Recruiting - verified December 2010 - Condition: Prostate Cancer
Interventions: Behavioral: Sexual Medicine Rehabilitation Program + nurse practitioner information phone calls; Behavioral: Sexual Medicine Rehabilitation Program + Acceptance and Commitment Therapy for Erectile Dysfunction
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; National Institutes of Health (NIH); Center for Marital and Sexual Health of South Florida
Recruiting - verified November 2011 - Conditions: HIV Infection; Hepatitis C
Interventions: Drug: Anti-HIV Agents; Drug: raltegravir; Drug: Emtricitabine and tenofovir disoproxil fumarate
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Recruiting - verified August 2011 - Conditions: Nasal Polyp; Smoking; Rhinosinusitis; Allergic Rhinitis; Deviated Nasal Septum; ASA Intolerant Asthma
Intervention:
Sponsors: Karnataka Institute of Medical Sciences; Karnataka Institute of Medical Sciences; Ministry of Science and Technology, India; Applied Genetics; Lab Discoveries Ltd.
Recruiting - verified April 2012 - Condition: Fragile X Syndrome
Interventions: Drug: arbaclofen; Drug: placebo
Sponsors: Seaside Therapeutics, Inc.; Seaside Therapeutics, Inc.
Recruiting - verified March 2012 - Conditions: Influenza; Pneumonia, Viral; Pulmonary Fibrosis; Quality of Life; Stress Disorders, Post Traumatic
Intervention:
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified January 2012 - Condition: HIV-1 Infection
Interventions: Drug: Lopinavir/ritonavir; Drug: Lopinavir/ritonavir; Drug: Raltegravir; Drug: Emtricitabine/tenofovir disoproxil fumarate; Drug: Abacavir/lamivudine/zidovudine; Drug: Abacavir/lamivudine; Drug: Lamivudine/zidovudine; Drug: Abacavir; Drug: Zidovudine; Drug: Lamivudine
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified October 2011 - Conditions: Urinary Irritative/Incontinence Problems; Bowel Problems; Sexual Problems; Hormonal Problems; Phycological Problems
Intervention: Behavioral: RePCa A
Sponsors: Odense University Hospital; Odense University Hospital
Recruiting - verified January 2011 - Condition: Rectal Cancer
Intervention: Procedure: Percutaneous nerve evaluation
Sponsors: University of Aarhus; University of Aarhus
Recruiting - verified March 2012 - Condition: HIV Infection
Interventions: Drug: Efavirenz; Drug: Efavirenz
Sponsors: Kirby Institute; Kirby Institute; Chelsea and Westminster NHS Foundation Trust
Recruiting - verified February 2012 - Condition: Decubitis Ulcer
Intervention: Procedure: Indirect Calorimetry
Sponsors: Saint Elizabeth Regional Medical Center; Saint Elizabeth Regional Medical Center
Recruiting - verified July 2011 - Condition: Autism Spectrum Disorders
Interventions: Drug: Intranasal Oxytocin; Drug: Placebo
Sponsors: Montefiore Medical Center; Montefiore Medical Center; National Alliance for Research on Schizophrenia and Depression
Recruiting - verified April 2012 - Condition: HIV Infections
Interventions: Biological: Profectus HIV MAG pDNA vaccine; Biological: IL-12; Other: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: HIV-1 Infections
Interventions: Drug: Darunavir; Drug: ritonavir; Drug: Darunavir; Drug: ritonavir
Sponsors: Janssen R&D Ireland; Janssen R&D Ireland
Recruiting - verified April 2012 - Conditions: Lymphoma; Nonneoplastic Condition
Interventions: Genetic: DNA analysis; Genetic: RNA analysis; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); AIDS Associated Malignancies Clinical Trials Consortium; National Cancer Institute (NCI)
Recruiting - verified June 2011 - Condition: HIV Dementia
Intervention: Drug: Atorvastatin
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: Systemic Lupus Erythematosus
Intervention:
Sponsors: Children's Hospital of Philadelphia; Children's Hospital of Philadelphia
Recruiting - verified December 2011 - Condition: Sexual Dysfunction, Physiological
Intervention: Drug: PRILIGY (dapoxetine hydrochloride)
Sponsors: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Cegedim Strategic Data
Not yet recruiting - verified July 2011 - Conditions: Crystal Methamphetamine Abuse; Crystal Methamphetamine Dependence
Interventions: Behavioral: Behavioral Activation Therapy and Risk Reduction Counseling (BAT-RR); Behavioral: Information, Motivation, Behavioral skills change approach to sexual risk reduction
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Fenway Community Health
Recruiting - verified May 2012 - Condition: HIV-1 Infection
Intervention: Drug: Rilpivirine
Sponsors: Janssen R&D Ireland; Janssen R&D Ireland
Recruiting - verified April 2012 - Condition: HIV Infection
Interventions: Behavioral: Bruthas Project; Behavioral: Standard HIV Testing and Counseling
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institute of Mental Health (NIMH)
Recruiting - verified January 2012 - Condition: HIV Infections
Intervention: Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: HIV Infections
Interventions: Biological: PENNVAX-G DNA Vaccine; Biological: MVA-CMDR Vaccine; Biological: Placebo PENNVAX-G Vaccine; Biological: Placebo MVA-CMDR Vaccine
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: Tuberculosis
Interventions: Biological: GSK's investigational vaccine 692342; Biological: Physiological saline
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified January 2012 - Condition: Fragile X Syndrome
Interventions: Drug: AFQ056; Drug: AFQ056; Drug: AFQ056; Drug: Placebo
Sponsors: Novartis; Novartis
Recruiting - verified May 2012 - Conditions: HIV; AIDS; Opioid Dependence; Drug Dependence
Intervention: Drug: Depot Naltrexone
Sponsors: Yale University; Yale University; Baystate Medical Center
Recruiting - verified August 2011 - Conditions: Anal Cancer; Breast Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Lung Cancer; Nonneoplastic Condition; Ovarian Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboplatin; Drug: paclitaxel; Drug: vorinostat; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: National Cancer Institute (NCI); AIDS Associated Malignancies Clinical Trials Consortium; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Autism Spectrum Disorders
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Mclean Hospital
Recruiting - verified December 2011 - Conditions: Pleuropulmonary Blastoma; Cystic Nephroma; Ovarian Sertoli-Leydig Cell Tumors; Ocular Medulloepithelioma; Nasal Chondromesenchymal Hamartoma
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified August 2011 - Condition: HIV-1 Infection
Interventions: Drug: atorvastatin; Drug: atorvastatin
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Pfizer
Recruiting - verified September 2011 - Conditions: HIV; AIDS; Substance Use Disorders
Intervention: Behavioral: Resilient Affective Processing Therapy (RAPT)
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified March 2012 - Conditions: Pain; Schizophrenia
Intervention:
Sponsors: University Hospital, Strasbourg, France; University Hospital, Strasbourg, France
Recruiting - verified November 2010 - Condition: Kidney Diseases
Interventions: Dietary Supplement: Control; Dietary Supplement: Protein; Other: Protein + Exercise
Sponsors: University of Illinois at Urbana-Champaign; University of Illinois at Urbana-Champaign; University of Illinois
Recruiting - verified June 2011 - Condition: Idiopathic Short Stature
Interventions: Drug: Anastrozole and Letrozole; Drug: Somatropin; Drug: Aromatase inhibitor and somatropin
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic; Thrasher Research Fund; Genentech; Novartis; AstraZeneca
Recruiting - verified May 2012 - Conditions: Bacterial Vaginosis; Trichomoniasis; Candidiasis
Interventions: Drug: Placebo; Drug: Neo-Penotran® Forte (active ingredient Metronidazole & Miconazole Nitrate)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: HIV Infections
Interventions: Drug: lopinavir/ritonavir plus one nucleoside; Drug: lopinavir /ritonavir plus two nucleosides
Sponsors: The Huesped Foundation; The Huesped Foundation; Abbott
Recruiting - verified November 2010 - Condition: HIV-1 Infection
Interventions: Drug: Gentian Violet; Drug: Nystatin oral suspension
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2011 - Condition: HIV
Intervention:
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb; PharmaNet
Recruiting - verified January 2012 - Condition: Human Immunodeficiency Virus
Intervention: Drug: emtricitabine/tenofovir disoproxil fumarate
Sponsors: Henry Ford Health System; Henry Ford Health System
Recruiting - verified June 2011 - Conditions: Prostate Cancer Treated by Radiosurgery Early Risk; Prostate Cancer Treated by Radiosurgery Intermediate Risk
Intervention:
Sponsors: Florida Robotic Radiosurgery Association; Florida Robotic Radiosurgery Association
Recruiting - verified April 2012 - Condition: Essential Tremor
Intervention: Behavioral: Iowa Gambling Task and Ekman facial recognition test
Sponsors: University Hospital, Bordeaux; University Hospital, Bordeaux
Recruiting - verified December 2011 - Conditions: HIV Infections; Neutropenia; Anemia
Interventions: Drug: cotrimoxazole prophylaxis; Drug: cotrimoxazole placebo; Behavioral: exclusive breastfeeding until 6 months of age; Behavioral: exclusive breastfeeding for 12 months
Sponsors: Harvard School of Public Health; Harvard School of Public Health; Harvard University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: Essential Thrombocythaemia
Interventions: Drug: Anagrelide retard; Drug: Placebo
Sponsors: AOP Orphan Pharmaceuticals AG; AOP Orphan Pharmaceuticals AG
Recruiting - verified August 2011 - Conditions: HIV Infection; Bone Loss; Osteopenia; Osteoporosis
Intervention: Drug: Zoledronic acid
Sponsors: Emory University; Emory University
Recruiting - verified March 2012 - Condition: HIV Infection
Intervention: Drug: Hydroxychloroquine
Sponsors: St Stephens Aids Trust; St Stephens Aids Trust
Recruiting - verified December 2011 - Condition: HIV/AIDS
Intervention: Dietary Supplement: Multivitamin supplements B,C and E
Sponsors: Harvard School of Public Health; Harvard School of Public Health; Makerere University; Infectious Disease Institute, Kampala, Uganda
Recruiting - verified January 2012 - Conditions: HIV Infections; Heart Disease
Interventions: Drug: Rosuvastatin 10 mg. daily for 96 weeks; Drug: Placebo
Sponsors: University Hospitals of Cleveland; University Hospitals of Cleveland; National Institutes of Health (NIH); AstraZeneca
Recruiting - verified January 2012 - Conditions: Anal Cancer; Nonneoplastic Condition; Penile Cancer; Precancerous Condition
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); AIDS Associated Malignancies Clinical Trials Consortium; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Condition: Rectal Cancer
Intervention:
Sponsors: Karolinska Institutet; Karolinska Institutet; Swedish Cancer Society
Recruiting - verified April 2012 - Condition: Rectal Cancer
Intervention:
Sponsors: Karolinska Institutet; Karolinska Institutet; Swedish Cancer Society
Recruiting - verified April 2012 - Conditions: Chronic HIV Infection; HCV Coinfection
Intervention: Drug: Fosamprenavir
Sponsors: Fundacion SEIMC-GESIDA; Fundacion SEIMC-GESIDA; ViiV Healthcare
Recruiting - verified June 2011 - Conditions: Major Depressive Disorder; Dysthymia Disorder
Interventions: Drug: Oxytocin; Drug: Placebo
Sponsors: University of California, San Diego; University of California, San Diego
Recruiting - verified September 2010 - Condition: Erectile Dysfunction
Interventions: Drug: Placebo; Drug: One POMx capsule daily; Drug: 2 POMx Capsules
Sponsors: POM Wonderful LLC; POM Wonderful LLC; Target Health Inc.
Recruiting - verified June 2011 - Condition: HIV
Intervention: Drug: Tenofovir/emtricitabine and raltegravir
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston; Merck; Gilead Sciences
Recruiting - verified February 2012 - Condition: Human Immunodeficiency Virus
Interventions: Drug: high dose of MSC; Drug: low dose of MSC treatment
Sponsors: Beijing 302 Hospital; Beijing 302 Hospital
Recruiting - verified September 2010 - Condition: Human Papillomavirus (HPV)
Intervention: Other: Survey
Sponsors: Children's Memorial Hospital; Children's Memorial Hospital
Recruiting - verified July 2011 - Conditions: HIV Infection; Young Adult
Intervention: Biological: blood sampling, specific biological exams and biobank and self administered questionnaires
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis; Pr Boccara Service Cardiologie Hôpital St Antoine PARIS; Dr Vigouroux Fac PM Curie Inserm U938 PARIS; Dr Carlier Service Radiologie Imagerie Médicale Hôpital Raymond Poincarré GARCHES; Dr Kolta Service Rhumatologie Hôpital Cochin PARIS; Dr Appay Immunologie Inserm U945 Hôpital Pitié Salpétrière PARIS; Pr Rouzioux Virologie, Bactériologie Hôpital Necker PARIS; Dr Treluyer CIC Necker PARIS
Recruiting - verified August 2011 - Condition: HIV Positive Patient Receive Implant Supported Restoration
Intervention:
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; Astra Tech AB
Recruiting - verified February 2012 - Condition: HIV
Intervention: Behavioral: Effectiveness of different strategies in HIV testing and linkage to care
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH)
Recruiting - verified January 2011 - Condition: Drug Resistance
Intervention:
Sponsors: Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; Clinical Centre of Serbia; National Institute of Infectious Diseases Matei Bals; University Hospital, Geneva; Canisius-Wilhelmina Hospital; Universiteit Antwerpen
Recruiting - verified September 2010 - Conditions: HIV; AIDS
Intervention:
Sponsors: George Washington University; George Washington University; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Conditions: Human Immunodeficiency Virus (HIV); Hepatitis C, Chronic
Intervention:
Sponsors: George Washington University; George Washington University
Recruiting - verified September 2010 - Conditions: Trachoma; Chlamydia
Intervention: Drug: mass treatment with oral azithromycin
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified April 2012 - Condition: HIV Infections
Interventions: Behavioral: Affect Management; Behavioral: General Health Promotion
Sponsors: Rhode Island Hospital; Rhode Island Hospital
Recruiting - verified July 2011 - Conditions: Androgen Deficiency; AD; Erectile Dysfunction; ED; Cardiovascular Adverse Events; Cerebrovascular Adverse Events
Intervention:
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified November 2011 - Condition: Infection, Human Immunodeficiency Virus I
Intervention: Drug: ZIAGEN®
Sponsors: ViiV Healthcare; ViiV Healthcare; GlaxoSmithKline
Recruiting - verified June 2011 - Conditions: Hiv Infection; Lung Cancer
Intervention: Radiation: Low dose computed tomography (CT)
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - verified January 2012 - Conditions: Male Erectile Disorder; Prostate Cancer; Therapy-related Toxicity; Urinary Incontinence
Interventions: Other: questionnaire administration; Procedure: assessment of therapy complications; Procedure: high-intensity focused ultrasound ablation; Procedure: multiparametric magnetic resonance imaging; Procedure: quality-of-life assessment; Procedure: transperineal prostate biopsy; Procedure: transrectal prostate biopsy
Sponsors: National Cancer Institute (NCI); University College London Hospitals
Recruiting - verified November 2010 - Conditions: HIV; Sexually Transmitted Diseases
Interventions: Behavioral: STYLEnS; Behavioral: Health Promotion
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute
Recruiting - verified March 2012 - Conditions: Burkitt Lymphoma; Malaria; Epstein-Barr Virus
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified May 2011 - Condition: Major Depressive Disorder (MDD)
Interventions: Drug: LY2216684; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Interventions: Drug: LY2216684; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Fragile X Syndrome; FMR1 Premutation; Primary Ovairan Insufficiency; Premature Ovarian Failure; Premature Menopause
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified July 2011 - Conditions: HIV; AIDS; Indicator Diseases/Indicator Conditions
Interventions: Other: HIV test (serological or salivary); Other: Interview
Sponsors: Chelsea and Westminster NHS Foundation Trust; Chelsea and Westminster NHS Foundation Trust; HIV in Europe (Co-Sponsor)
Recruiting - verified October 2009 - Condition: Human Immunodeficiency Virus
Interventions: Drug: tenofovir/emtricitabine/efavirenz (TDF/FTC/EFV); Drug: tenofovir/emtricitabine (TDF/FTC); Drug: Atazanavir (ATV); Drug: Ritonavir; Procedure: Phlebotomy
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; Society of Infectious Diseases Pharmacists; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Condition: Posttraumatic Stress Disorder
Interventions: Drug: Mirtazapine; Drug: Sertraline; Other: Sugar pill
Sponsors: Research Foundation for Mental Hygiene; Research Foundation for Mental Hygiene; National Institute of Mental Health (NIMH)
Recruiting - verified July 2010 - Condition: Antiretroviral Therapy in HIV-1 Infected Children
Interventions: Drug: Kaletra dosed once daily; Drug: kaletra dosed twice daily
Sponsors: PENTA Foundation; PENTA Foundation; Medical Research Council; French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting - verified February 2012 - Condition: Major Depressive Disorder
Interventions: Drug: LY2216684; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Squamous Cell Carcinoma of the Oropharynx
Intervention: Behavioral: questionnaire and semi-structured interviews
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified February 2012 - Conditions: Risk Reduction Behavior; Health Behavior; Sexual Behavior; Adolescent Behavior; Cannabis
Interventions: Behavioral: INFORMATION-ONLY SEXUAL RISK REDUCTION (INFO-ONLY); Behavioral: SEXUAL PLUS ALCOHOL RISK REDUCTION (SRRI+ETOH); Behavioral: SEXUAL + ALCOHOL + MARIJUANA RISK REDUCTION
Sponsors: University of New Mexico; University of New Mexico; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified August 2011 - Condition: Type 1 Diabetes Mellitus
Intervention: Procedure: Blood draw
Sponsors: City of Hope Medical Center; City of Hope Medical Center
Recruiting - verified March 2012 - Condition: Obesity, Morbid
Interventions: Procedure: laparoscopic adjustable gastric band; Behavioral: Combined life style interventions
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Recruiting - verified October 2011 - Condition: HIV-1 Infection
Intervention: Biological: JS7 plasmid DNA and MVA62B vaccine
Sponsors: GeoVax, Inc.; GeoVax, Inc.; AIDS Research Consortium of Atlanta; University of Alabama at Birmingham; AIDS Research Alliance
Recruiting - verified December 2011 - Conditions: Pulmonary Arterial Hypertension; HIV Infection; Congenital Heart Defect; Systemic Sclerosis; Connective Tissue Disease
Interventions: Procedure: skin biopsy; Other: Blood Sample
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified August 2011 - Condition: HIV
Interventions: Behavioral: Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test; Device: Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test
Sponsors: University of Washington; University of Washington; Public Health - Seattle and King County; National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Condition: Obesity
Interventions: Drug: Leuprolide; Drug: Testosterone
Sponsors: Mayo Clinic; Mayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Abbott
Recruiting - verified January 2012 - Condition: Contraception
Interventions: Drug: levonorgestrel patch with BMI 32 kg/m2 to <40 kg/m2; Drug: levonorgestrel patch with BMI <32 kg/m2; Drug: levonorgestrel patch with BMI 32 kg/m2 to <40 kg/m2; Drug: levonorgestrel patch with BMI <32 kg/m2
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Health Decisions
Recruiting - verified February 2012 - Conditions: Kidney Donation; Kidney Failure; Kidney Transplantation
Interventions: Other: Glomerular Filtration Rate with Iothalamate; Other: Glomerular Filtration Rate with Iohexol
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); National Heart, Lung, and Blood Institute (NHLBI); Health Resources and Services Administration (HRSA)
Recruiting - verified February 2012 - Conditions: HIV; AIDS; Epidemiology; Prevention
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified April 2012 - Condition: Pelvic Inflammatory Disease
Interventions: Drug: ceftriaxone, doxycycline, and placebo; Drug: ceftriaxone, doxycycline, metronidazole
Sponsors: University of Pittsburgh; Harold Wiesenfeld; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Conditions: Hypogonadotropic Hypogonadism; Type 2 Diabetes
Interventions: Drug: testosterone; Drug: clomiphene; Drug: placebo; Drug: placebo
Sponsors: State University of New York at Buffalo; State University of New York at Buffalo; American Diabetes Association
Recruiting - verified July 2011 - Condition: HIV Infection
Interventions: Behavioral: Linkage-to-Care Component: Financial Incentive (FI); Behavioral: Linkage-to-Care Component: Standard of Care (SOC); Behavioral: Viral Suppression Component: FI; Behavioral: Viral Suppression Component: SOC; Behavioral: Prevention for Positives Component: Counseling and SOC; Behavioral: Prevention for Positives Component: SOC
Sponsors: HIV Prevention Trials Network; HIV Prevention Trials Network; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2012 - Condition: HIV Infection
Intervention: Drug: Raltegravir
Sponsors: Southern California Institute for Research and Education; Southern California Institute for Research and Education; Merck
Recruiting - verified May 2012 - Condition: Orthostatic Intolerance
Interventions: Drug: 17 beta estradiol, progesterone, ganirelix acetate; Drug: 17 beta estradiol, progesterone, ganirelix acetate
Sponsors: Yale University; Yale University
Recruiting - verified August 2011 - Condition: Stroke
Intervention:
Sponsors: UPECLIN HC FM Botucatu Unesp; UPECLIN HC FM Botucatu Unesp
Recruiting - verified July 2011 - Condition: Chlamydia
Interventions: Drug: ceftriaxone; Drug: Azithromycin
Sponsors: University of Pittsburgh; Thomas L. Cherpes, MD; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Conditions: Tuberculosis; HIV Infections
Interventions: Biological: MVA85A/AERAS-485; Biological: Candida albicans Skin Test Antigen
Sponsors: Aeras Global TB Vaccine Foundation; Aeras Global TB Vaccine Foundation; University of Oxford; European and Developing Countries Clinical Trials Partnership (EDCTP)
Recruiting - verified August 2011 - Condition: Non Small Cell Lung Cancer
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Conditions: HIV Infections; Hepatitis; Sexually Transmitted Infections
Interventions: Behavioral: Traditional Prevention; Behavioral: Web-based Prevention
Sponsors: National Development and Research Institutes, Inc.; National Development and Research Institutes, Inc.; National Institute on Drug Abuse (NIDA)
Recruiting - verified July 2011 - Condition: Provoked Vestibulodynia
Intervention: Device: LOW LEVEL LASER SYSTEM
Sponsors: Hadassah Medical Organization; Hadassah Medical Organization
Recruiting - verified January 2012 - Conditions: Stimulant-Related Disorders; HIV; HIV Infections
Intervention: Drug: Truvada
Sponsors: Friends Research Institute, Inc.; Friends Research Institute, Inc.; University of California, Los Angeles
Recruiting - verified October 2011 - Condition: Anemia
Interventions: Biological: Sotatercept; Biological: Placebo
Sponsors: Celgene Corporation; Celgene Corporation; Acceleron Pharma, Inc.
Recruiting - verified March 2012 - Conditions: HIV; AIDS
Intervention: Behavioral: Skills Building - Motivational Interviewing
Sponsors: Boston Medical Center; Boston Medical Center
Recruiting - verified June 2011 - Condition: HIV Positive
Intervention:
Sponsors: University of California, San Diego; Zuniga De Nuncio, Maria; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified March 2012 - Condition: HIV-1 Infections
Interventions: Biological: ChAdV63.HIVconsv low dose.; Biological: ChAdV63.HIVconsv high dose.; Biological: pSG2.HIVconsv; Biological: MVA.HIVconsv; Other: Placebo
Sponsors: University of Oxford; University of Oxford
Recruiting - verified February 2012 - Condition: HIV Infections
Interventions: Drug: Tenofovir 1% gel; Other: Placebo gel
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Conditions: HIV/AIDS; HIV Infections
Interventions: Drug: Efavirenz; Drug: Lopinavir/ritonavir (LPV/r); Drug: D4T; Drug: Abacavir (ABC)
Sponsors: Columbia University; Columbia University; University of Witwatersrand, South Africa; National Institutes of Health (NIH)
Recruiting - verified February 2012 - Conditions: HIV-1 Infection; Neuropathic Pain
Intervention: Drug: pregabalin (Lyrica)
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Renal Cell Carcinoma
Intervention: Drug: Hydroxychloroquine (HC)
Sponsors: University of Pittsburgh; University of Pittsburgh; National Institutes of Health (NIH)
Recruiting - verified January 2012 - Conditions: HIV Infections; Menopause
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified January 2012 - Condition: HIV Infections
Intervention: Drug: ATV/r
Sponsors: The HIV Netherlands Australia Thailand Research Collaboration; The HIV Netherlands Australia Thailand Research Collaboration; Kirby Institute; National Health Security Office (NHSO)
Recruiting - verified March 2012 - Conditions: Hazardous Alcohol Use; Binge Drinking; High Risk Sexual Behaviors; HIV Risk Reduction; HIV Infection
Interventions: Behavioral: Computerized brief alcohol intervention with IVR booster calls; Behavioral: Computer delivered brief alcohol intervention; Behavioral: Attention Control
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Not yet recruiting - verified June 2011 - Conditions: HIV Medication Adherence; Methamphetamine Use; Sexual Risk; Poly-substance Use; HIV Infections
Interventions: Behavioral: Motivational Interviewing + Cognitive Behavioral Skills Training; Behavioral: Education Attention Control
Sponsors: Hunter College; Hunter College
Recruiting - verified June 2011 - Condition: HIV Infections
Intervention:
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Alcoholism; HIV Infections
Interventions: Behavioral: Couples Intervention; Behavioral: Women's CoOp; Behavioral: Women's CoOp and Men's Intervention
Sponsors: RTI International; RTI International; National Institute on Alcohol Abuse and Alcoholism (NIAAA); Medical Research Council, South Africa
Recruiting - verified December 2011 - Conditions: Substance Abuse; HIV Infections
Intervention: Behavioral: Stonewall Project
Sponsors: University of California, San Francisco; University of California, San Francisco; California HIV/AIDS Research Program
Recruiting - verified March 2012 - Conditions: Pain; Ventilatory Depression
Intervention: Drug: hydromorphone
Sponsors: Northwestern University; Northwestern University
Recruiting - verified February 2012 - Condition: HIV Infections
Interventions: Drug: AZT-3TC-LPV/r twice a day; Drug: ABC-3TC-EFV once a day; Drug: ABC-3TC-LPV/r once a day
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis; European and Developing Countries Clinical Trials Partnership (EDCTP); Public Research Centre Health, Luxembourg; Ministry of Foreign Affairs, Luxembourg; University of Ouagadougou, Burkina Faso; Programme national,ANRS,Coopération française-Côte d'Ivoire (PAC-CI), Côte d'Ivoire; Ministry of Health, Rwanda; Institut National de la Santé Et de la Recherche Médicale, France; University of Bordeaux; Institut de Sante Publique, d'Epidémiologie et de Développement; Université Montpellier; University of Paris 5 - Rene Descartes; Queen Fabiola Children's University Hospital
Recruiting - verified December 2011 - Condition: Fragile X Syndrome
Interventions: Drug: donepezil hydrochloride; Drug: sugar pill
Sponsors: Stanford University; Stanford University; National Institute of Mental Health (NIMH); Autism Speaks
Recruiting - verified July 2011 - Condition: Asthma
Intervention: Behavioral: Telephone counseling intervention
Sponsors: University of Michigan; University of Michigan
Recruiting - verified July 2011 - Conditions: Rheumatoid Arthritis; Cardiovascular Disease
Intervention:
Sponsors: University of Arkansas; University of Arkansas
Recruiting - verified December 2011 - Conditions: Cancer Survivor; Male Erectile Disorder; Prostate Cancer; Radiation Toxicity
Interventions: Dietary Supplement: L-arginine/Korean ginseng/ Gingko biloba/damiana-based supplement; Other: placebo
Sponsors: National Cancer Institute (NCI); Wake Forest University; National Cancer Institute (NCI)
Not yet recruiting - verified August 2011 - Condition: Attention Deficit Hyperactivity Disorder
Intervention:
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified November 2011 - Condition: Contraception
Interventions: Drug: ellaOne® (ulipristal acetate); Drug: ellaOne® (ulipristal acetate)
Sponsors: HRA Pharma; HRA Pharma
Recruiting - verified March 2012 - Condition: Erectile Dysfunction
Intervention: Drug: Vardenafil (Levitra, BAY38-9456)
Sponsors: Bayer; Bayer
Recruiting - verified May 2012 - Condition: HIV/AIDS
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; University of California, San Francisco; Department of Health and Human Services; Mbarara University of Science and Technology; University of British Columbia; Dana-Farber Cancer Institute
Recruiting - verified May 2012 - Conditions: HIV Infections; Hepatitis C
Interventions: Drug: Raltegravir; Drug: Atazanavir/Ritonavir
Sponsors: St. James's Hospital; St. James's Hospital
Recruiting - verified March 2010 - Conditions: HIV; Substance Abuse; HIV Infections
Interventions: Drug: Oral Naltrexone (ON); Drug: Implantable Naltrexone (IN)
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified January 2012 - Condition: HIV-1 Infections
Interventions: Drug: Darunavir; Drug: ritonavir; Drug: ritonavir; Drug: Darunavir; Drug: ritonavir; Drug: Darunavir; Drug: Darunavir; Drug: Darunavir; Drug: ritonavir; Drug: Darunavir; Drug: ritonavir; Drug: Darunavir; Drug: Darunavir; Drug: ritonavir
Sponsors: Janssen R&D Ireland; Janssen R&D Ireland
Recruiting - verified April 2012 - Conditions: Birth Defects; Infection, Human Immunodeficiency Virus
Intervention: Drug: Any Antiretroviral Therapy
Sponsors: ViiV Healthcare; ViiV Healthcare; GlaxoSmithKline
Recruiting - verified February 2012 - Condition: HIV Infections
Intervention: Procedure: Blood collection
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Trinitrin; Drug: Neosynephrine 10% collyrium; Drug: Iontophoresis with acetylcholine delivery; Device: Dynamic Vessel Analyzer
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2011 - Conditions: HIV Prevention; HIV Infections
Intervention: Drug: Raltegravir
Sponsors: St Vincent's Hospital, Sydney; St Vincent's Hospital, Sydney; Merck
Recruiting - verified August 2010 - Conditions: Breast Cancer; Gynecologic Cancer
Intervention:
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified December 2011 - Conditions: Prostate Cancer; Erectile Dysfunction
Intervention: Biological: injection of bone marrow mononucleated cells
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified April 2011 - Condition: Polycystic Ovary Syndrome
Intervention: Behavioral: Nutrition Education, Dietary Counseling, and Cooking
Sponsors: Children's Hospital Boston; Children's Hospital Boston; Thrasher Research Fund
Recruiting - verified June 2011 - Condition: Thrombosis
Intervention: Drug: Low molecular weight heparin
Sponsors: Third Military Medical University; Third Military Medical University; Chongqing Medical University
Recruiting - verified January 2012 - Conditions: HIV; HIV Infections
Intervention:
Sponsors: George Washington University; George Washington University
Recruiting - verified September 2010 - Conditions: Alcohol Dependence; Problem Drinking; Hazardous Drinking; Human Immunodeficiency Virus; AIDS
Interventions: Drug: Vivitrol- Intramuscular naltrexone (depot-formulation); Drug: Placebo
Sponsors: Yale University; Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified August 2011 - Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
Sponsors: Abbott; Abbott; Veeda Clinical Research, Belgium
Recruiting - verified January 2012 - Condition: Human Immunodeficiency Virus
Interventions: Drug: lopinavir/ritonavir; Drug: Raltegravir
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: HIV Infection
Interventions: Biological: AGS-004; Biological: Placebo
Sponsors: Argos Therapeutics; Argos Therapeutics
Recruiting - verified November 2011 - Condition: Transsexualism
Interventions: Drug: Testolactone undecanoate; Drug: Lynestrenol; Drug: Cyproterone Acetate; Drug: Estradiol; Drug: 5-alpha reductase inhibitor
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified November 2011 - Condition: HIV Infections
Intervention: Drug: Tenofovir disoproxil fumarate (TDF)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Gilead Sciences
Recruiting - verified May 2012 - Condition: HIV Infections
Interventions: Drug: Zidovudine (ZDV); Drug: Nevirapine (NVP); Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]); Drug: Lamivudine-Zidovudine (3TC-ZDV); Drug: Lopinavir-ritonavir (LPV-RTV); Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]); Drug: Nevirapine (NVP); Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]); Drug: Lopinavir/ritonavir (LPV-RTV); Drug: Nevirapine (NVP); Drug: Lopinavir-ritonavir (LPV-RTV); Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]); Drug: Cotrimoxazole (CTX); Drug: Placebo CTX
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: Critical Limb Ischemia
Interventions: Genetic: VM202; Genetic: VM202; Other: Normal Saline
Sponsors: ViroMed Co., Ltd.; ViroMed Co., Ltd.; VM Biopharma
Recruiting - verified February 2012 - Condition: HIV Infection
Intervention: Biological: blood test at day one
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - verified August 2011 - Condition: HIV Infection
Intervention:
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: HIV Infections
Intervention:
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Conditions: Influenza; (Influenza A and Subtypes Such as H3N2 and 2009 H1N1 or Influenza B)
Intervention:
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH)
Recruiting - verified April 2012 - Conditions: Postmenopause; Overweight
Interventions: Behavioral: Placebo + exercise; Dietary Supplement: Phytoestrogens without exercise; Other: Phytoestrogens + exercise; Other: Placebo without exercise
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke; Canadian Institutes of Health Research (CIHR); Centre de recherche sur le vieillissement du CSSS-IUGS
Recruiting - verified June 2010 - Condition: Hypothalamic Obesity
Intervention: Drug: Exenatide
Sponsors: Children's Hospitals and Clinics of Minnesota; Children's Hospitals and Clinics of Minnesota; Amylin Pharmaceuticals, Inc.
Recruiting - verified June 2011 - Condition: Impulse Control Disorders in Parkinson's Disease
Intervention: Drug: Naltrexone
Sponsors: University of Pennsylvania; University of Pennsylvania; Michael J. Fox Foundation for Parkinson's Research
Recruiting - verified November 2011 - Conditions: Adenocarcinoma of the Prostate; Recurrent Prostate Cancer
Interventions: Other: laboratory biomarker analysis; Procedure: quality-of-life assessment; Other: questionnaire administration; Drug: cinacalcet hydrochloride
Sponsors: Comprehensive Cancer Center of Wake Forest University; Comprehensive Cancer Center of Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Conditions: Malaria in Pregnancy; HIV Infections
Interventions: Drug: Cotrimoxazole prophylaxis; Drug: SP IPT
Sponsors: Institute of Tropical Medicine, Belgium; Institute of Tropical Medicine, Belgium; Tropical Diseases Research Centre, Zambia
Recruiting - verified April 2012 - Conditions: HIV; HIV Infections
Intervention: Drug: Valacyclovir
Sponsors: University of Washington; University of Washington
Recruiting - verified November 2011 - Condition: Prostate Cancer
Intervention: Drug: sildenafil 100mg
Sponsors: Seoul National University Bundang Hospital; Seoul National University Bundang Hospital; Pfizer
Recruiting - verified August 2011 - Condition: Ovarian Cancer
Interventions: Biological: bleomycin sulfate; Drug: carboplatin; Drug: cisplatin; Drug: etoposide phosphate; Drug: paclitaxel
Sponsors: National Cancer Institute (NCI); Gynecologic Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: HIV Infection; HIV Infections
Intervention: Genetic: SB-728-T
Sponsors: Sangamo Biosciences; Sangamo Biosciences
Recruiting - verified December 2011 - Conditions: HIV; HIV Infections
Intervention: Drug: Raltegravir
Sponsors: Centers for Disease Control and Prevention, China; Centers for Disease Control and Prevention, China; Merck
Recruiting - verified June 2011 - Conditions: HIV-related Lymphoma; HIV Infections
Intervention: Other: Rituximab and CHOP regimen + PBSCT
Sponsors: Azienda Ospedaliera Spedali Civili di Brescia; Azienda Ospedaliera Spedali Civili di Brescia
Recruiting - verified January 2012 - Conditions: HIV Infection; HIV Infections
Intervention:
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Gynecologic Cancer
Intervention: Behavioral: Surveys
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified April 2012 - Conditions: High Triglyceride Level; HIV Infection
Intervention: Drug: Lovaza
Sponsors: Tufts University; Todd Conley; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified November 2011 - Condition: HIV Infections
Interventions: Drug: Emtricitabine (FTC); Drug: Tenofovir disoproxil fumarate (TDF); Drug: Efavirenz (EFV)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: HIV Infection
Intervention:
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis; Collect cell and immune study; Dr Yassine Taoufik Dr Houria Chavez Hôpital Bicêtre CIB Paris Sud France; Dr Guislaine Garcelain Hôpital Pitié Slapétrière Paris France; Virology study; Dr Patrice Morand et Veronique Boyer CHU Grenoble France Dr Corinne Amiel Hopital Tenon Paris France; Dr Irène Joab Hôpital Paul Brousse Villejuif France; Anatomo-pathologie; Pr Martine Raphael et Madame Patricia Rincé Hôpital Bicêtre France; Génétique des tumeurs; Dr Alex Duval Fondation Jean Dausset CEPH
Recruiting - verified January 2012 - Condition: Human Papillomavirus Infection
Interventions: Biological: GSK Biologicals' HPV vaccine 580299; Biological: Merck's Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Human Papillomavirus
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2011 - Condition: HIV Infections
Intervention:
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2011 - Conditions: HIV Infections; Acquired Immunodeficiency Syndrome; Medication Adherence
Intervention: Behavioral: MedCHEC tablet computer and Adherence Care
Sponsors: Boston University; Boston University; National Institute of Mental Health (NIMH); Department of Veterans Affairs; VA Boston Healthcare System; VA Greater Los Angeles Healthcare System; San Diego State University; Tufts University
Recruiting - verified February 2012 - Conditions: HIV Infection; Liver Failure; Liver Transplantation
Intervention: Drug: Raltegravir potassium
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis; Merck
Recruiting - verified December 2011 - Conditions: Sexual Dysfunction, Physiological; Ejaculation
Interventions: Drug: Dapoxetine hydrochloride; Other: Alternate care/non-dapoxetine hydrochloride treatment(s)
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Recruiting - verified May 2012 - Conditions: Psoriasis; Cardiovascular Diseases; Dyslipidemia
Intervention:
Sponsors: George Washington University; George Washington University
Recruiting - verified October 2011 - Conditions: HIV Infection; Osteopenia; Osteoporosis
Intervention:
Sponsors: Emory University; Emory University; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified March 2012 - Condition: HIV Infections
Interventions: Other: CARE+ Kenya brief computer risk assessment session; Other: CARE+ Kenya computer counseling session
Sponsors: New York University; New York University; Indiana University; Moi University
Recruiting - verified February 2012 - Condition: HIV Infections
Interventions: Other: CARE+ Spanish computer counseling session; Other: CARE+ Spanish brief computer risk assessment session
Sponsors: New York University; New York University; St. Luke's-Roosevelt Hospital Center
Recruiting - verified February 2012 - Conditions: Oxytocin; Placebo
Interventions: Drug: intranasal oxytocin; Drug: Placebo; Behavioral: Social support; Behavioral: No Social Support; Other: Female gender; Other: Male Gender
Sponsors: Harvard School of Public Health; Harvard School of Public Health; Brigham and Women's Hospital
Recruiting - verified June 2011 - Conditions: HIV Infections; Hepatitis C Virus
Intervention:
Sponsors: Rockefeller University; Rockefeller University
Recruiting - verified February 2012 - Condition: Ambiguous Genitalia
Intervention:
Sponsors: Meir Medical Center; Meir Medical Center
Recruiting - verified March 2012 - Condition: HIV Infections
Interventions: Drug: Efavirenz; Drug: Efavirenz
Sponsors: Kirby Institute; Kirby Institute
Recruiting - verified November 2011 - Condition: Anxiety Disorders
Interventions: Drug: Oxytocin; Drug: Placebo
Sponsors: University of California, San Diego; University of California, San Diego
Recruiting - verified October 2011 - Condition: Klinefelter Syndrome
Intervention:
Sponsors: University of Aarhus; University of Aarhus; Aarhus University Hospital
Recruiting - verified March 2012 - Condition: HIV Infections
Intervention: Behavioral: Modified client adherence profiling and intervention tailoring (CAP-IT)
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Conditions: Prostate Cancer; Sexual Dysfunction
Interventions: Other: laboratory biomarker analysis; Other: questionnaire administration; Procedure: assessment of therapy complications; Procedure: high-intensity focused ultrasound ablation; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); University College London Hospitals
Recruiting - verified May 2011 - Conditions: Malaria; HIV Infections
Interventions: Drug: Lopinavir/ritonavir; Drug: Efavirenz; Drug: Zidovudine; Drug: Lamivudine
Sponsors: University of California, San Francisco; University of California, San Francisco; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified September 2011 - Condition: HIV Infections
Interventions: Biological: WT-gag-TCR modified T cells; Biological: α/6-gag-TCR modified T cells; Other: STI or Drug Holiday
Sponsors: University of Pennsylvania; University of Pennsylvania; Adaptimmune Ltd.
Recruiting - verified January 2012 - Condition: C. Trachomatis
Interventions: Drug: Azithromycin; Drug: Doxycycline
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: HIV Infections
Interventions: Behavioral: Enhanced nursing telephone support; Behavioral: Standard care
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2011 - Conditions: Nevirapine Induced Rash; Nevirapine Induced Hepatitis; HIV; Adverse Side Effects; AIDS; HIV Infections
Interventions: Genetic: Genetic test for NVP induced rash; Other: 3TC/D4T/NVP or 3TC/AZT/NVP
Sponsors: Mahidol University; Mahidol University; Department of Medicine,Ramathibodi Hospital; Chulalongkorn University; Bamrasnaradura Institute, Ministry of Public Health; Thammasat University; Department of Preventive Medicine,Srinakharinwirot University; Chiang Rai Hospital; Maharaj Nakornratchasima Hospital; Department of Internal Medicine,Sawanpracharak Hospital; Department of Internal Medicine,Burirum Hospital; Department of Internal Medicine,Nakornping Hospital; National Institute of Health, Department of Medical Sciences; Clinical Research Center,Ministry of Public Health; RIKEN
Recruiting - verified July 2010 - Conditions: Atrophic Vaginitis; Breast Cancer
Intervention: Drug: Vagifem® (vaginal 17β-estradiol) questionnaire & menopause symptom checklist
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified April 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Cyclosporine
Sponsors: University of Pittsburgh; University of Pittsburgh; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified September 2011 - Conditions: HIV-1; HIV Infections
Intervention: Biological: MVA.HIVA
Sponsors: Medical Research Council; Medical Research Council; European and Developing Countries Clinical Trials Partnership (EDCTP)
Recruiting - verified September 2009 - Conditions: Malaria; HIV Infections
Interventions: Drug: LPV/r + 2 NRTIs; Drug: NVP or EFV + 2 NRTIs
Sponsors: University of California, San Francisco; University of California, San Francisco; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified November 2011 - Condition: HIV Infections
Interventions: Drug: Raltegravir (RAL); Drug: Atazanavir (ATV); Drug: Ritonavir (RTV); Drug: Tenofovir (TDF); Drug: Etravirine (ETV); Drug: Darunavir (DRV); Drug: Maraviroc (MVC); Drug: Lopinavir/ritonavir (LPV/r)
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Conditions: HIV Infections; HIV-1
Intervention: Drug: Etravirine
Sponsors: Janssen R&D Ireland; Janssen R&D Ireland
Recruiting - verified April 2012 - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: LY2216684
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Infertility; HIV Infections
Interventions: Other: Sperm washing and testing for HIV contamination; Procedure: Intrauterine Insemination
Sponsors: University of Missouri-Columbia; University of Missouri-Columbia
Available - verified September 2011 - Conditions: Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Nasal Type Extranodal NK/T-cell Lymphoma; AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Burkitt Lymphoma; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; de Novo Myelodysplastic Syndromes; HIV-associated Hodgkin Lymphoma; Juvenile Myelomonocytic Leukemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Secondary Myelodysplastic Syndromes
Interventions: Procedure: leukapheresis; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: autologous hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation; Other: laboratory biomarker analysis; Other: DNA analysis; Other: RNA analysis; Other: flow cytometry; Other: reverse transcriptase-polymerase chain reaction; Other: nucleic acid sequencing; Other: protein expression analysis
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Conditions: Cardiovascular Disease; HIV; Atherosclerosis; Inflammation; Statins, HMG-CoA; HIV Infections
Interventions: Drug: atorvastatin; Drug: Placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Condition: Prostate Cancer
Intervention: Radiation: Stereotactic Radiosurgery using the Novalis Tx
Sponsors: San Diego Radiosurgery; San Diego Radiosurgery
Recruiting - verified August 2011 - Condition: HIV Infections
Intervention:
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Conditions: HIV Infections; Pneumococcal Infections
Interventions: Biological: 13-valent Pneumococcal Conjugate Vaccine (13vPnC); Biological: 23-valent Pneumococcal Polysaccharide Vaccine (23vPS); Procedure: Blood draw; Procedure: Blood draw
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Conditions: Penile Cancer; Erectile Dysfunction; Radical Prostatectomy
Interventions: Drug: Placebo QHS and sildenafil and questionnaires; Drug: Sildenafil and questionnaire; Drug: Trimix combination (Papavarine 30mg/mL Phentholamine 1mg/mL Prostaglandin E1 10 mcg/mmL) and questionnaires
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Pfizer
Recruiting - verified January 2012 - Condition: HIV Infections
Intervention: Drug: Highly active antiretroviral therapy (HAART)
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: HIV Infections
Intervention: Drug: Etravirine (Intelence)
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; Janssen Pharmaceuticals
Recruiting - verified December 2011 - Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA-016-00-VP; Biological: VRCHIVADV014-00-VP
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Rilonacept
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center
Recruiting - verified December 2010 - Conditions: HIV; Depression; HIV Infections
Interventions: Behavioral: Cognitive behavioral therapy (CBT) for adherence and depression (CBT-AD); Behavioral: Life-steps adherence treatment; Behavioral: Information and supportive psychotherapy (ISP) for adherence and depression (ISP-AD)
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institute of Mental Health (NIMH)
Recruiting - verified January 2012 - Conditions: Sickle Cell Disease; Priapism
Interventions: Drug: sildenafil; Other: placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH)
Recruiting - verified June 2011 - Condition: Post-Traumatic Stress Disorder
Interventions: Behavioral: Cognitive Processing Therapy (CPT); Behavioral: Cognitive Processing Therapy (CPT)
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Locally Advanced Rectal Cancer
Intervention: Procedure: Omission of surgery or transanal endoscopic microsurgery, combined with intensive follow-up
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Recruiting - verified July 2011 - Condition: Metastatic Prostate Cancer
Interventions: Drug: Bevacizumab; Drug: Lenalidomide; Drug: Docetaxel; Drug: Prednisone
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified January 2012 - Condition: Traumatic Brain Injury
Interventions: Drug: Premarin IV; Drug: Placebo
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; University of Washington; Resuscitation Outcomes Consortium
Recruiting - verified September 2009 - Condition: Gonococcal Infections
Interventions: Drug: Azithromycin; Drug: Gemifloxacin; Drug: Gentamicin
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Conditions: Psoriasis; Nonalcoholic Fatty Liver Disease
Intervention:
Sponsors: George Washington University; George Washington University
Recruiting - verified October 2011 - Condition: HIV Infections
Interventions: Drug: Isentress®; Drug: Celsentri®
Sponsors: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer; Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer; Merck; Abbott
Recruiting - verified July 2009 - Conditions: HIV Infection; Pulmonary TB
Intervention: Drug: ATT (Ethambutol, Pyrazinamide, INH, Rifampicin)
Sponsors: Tuberculosis Research Centre, India; Tuberculosis Research Centre, India
Recruiting - verified October 2011 - Conditions: HIV; HIV Infections
Interventions: Drug: emtricitabine/tenofovir + lopinavir/ritonavir (WHO recommended second line); Drug: abacavir + didanosine + lopinavir/ritonavir (WHO recommended second line); Drug: emtricitabine/tenofovir + darunavir + ritonavir (Second line strategy under evaluation)
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis; Gilead Sciences; Janssen Pharmaceutica N.V., Belgium
Recruiting - verified March 2012 - Comparing Blood Vessel Endothelial Function in HIV-Infected People and Matched HIV-Uninfected PeopleCondition: HIV Infection
Intervention:
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified November 2011 - Condition: HIV Infections
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified July 2011 - Condition: Hyperandrogenism
Intervention:
Sponsors: University of Virginia; University of Virginia; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2012 - Condition: HIV Infections
Interventions: Drug: Alendronate; Drug: Alendronate placebo; Dietary Supplement: Calcium carbonate/vitamin D
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2012 - Conditions: HIV Infections; Tobacco Dependence
Interventions: Drug: Varenicline; Drug: Placebo
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis; Pfizer
Recruiting - verified February 2012 - Conditions: Acute HIV Infection; HIV Infections
Intervention: Drug: Atripla
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; Bristol-Myers Squibb; Gilead Sciences
Recruiting - verified December 2011 - Condition: Breast Cancer
Interventions: Drug: Green tea extract supplement; Other: Placebo
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified January 2012 - Condition: Opiate Addiction
Interventions: Other: Brief Intervention with Buprenorphine initiation; Behavioral: Brief Intervention
Sponsors: Yale University; Yale University; National Institute on Drug Abuse (NIDA)
Recruiting - verified December 2011 - Condition: HIV Infections
Intervention: Biological: SAV001-H
Sponsors: Sumagen; Sumagen
Recruiting - verified March 2012 - Conditions: Cancer Survivor; Cervical Cancer; Psychosocial Effects of Cancer and Its Treatment
Interventions: Behavioral: telephone-based intervention; Other: counseling intervention; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: psychosocial assessment and care
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Prostate Cancer; Adenocarcinoma
Intervention: Radiation: Hypofractionated, image-guided, intensity-modulated external beam radiation
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Montefiore Medical Center
Recruiting - verified March 2012 - Conditions: Alcoholism; Alcohol Dependence; Post-Tramatic Stress Disorder; fMRI
Intervention: Drug: Aprepitant
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified December 2011 - Conditions: Hypercholesterolemia; HIV Infections
Interventions: Drug: Ezetimibe; Drug: Rosuvastatin (standard care)
Sponsors: University of British Columbia; University of British Columbia; Merck Frosst-Schering Pharma, G.P.
Recruiting - verified November 2011 - Conditions: Impotence; Prostatic Neoplasms
Interventions: Drug: Sildenafil therapy plus post-NSRRP HBO2T; Drug: Sildenafil therapy plus sham post-NSRRP HBO2T
Sponsors: Hartford Hospital; Hartford Hospital
Recruiting - verified April 2011 - Conditions: Quality of Life; Sexual Function; Urinary Incontinence; Anal Incontinence
Intervention: Behavioral: Structured Rehabilitation program
Sponsors: University Hospital of North Norway; University Hospital of North Norway; Helse Nord
Recruiting - verified November 2011 - Condition: Malignant Glioma
Intervention: Drug: Palonosetron (PALO)
Sponsors: Duke University; Duke University; Eisai Inc.; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified June 2011 - Condition: Turner Syndrome
Intervention:
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Institute of Mental Health (NIMH)
Recruiting - verified December 2011 - Conditions: Cryptococcal Meningitis; HIV Infections
Interventions: Drug: Fluconazole; Drug: Amphotericin B
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: HIV Infections
Intervention: Behavioral: Entre Culturas: Navigating Culture, Identity, and HIV Risk
Sponsors: Nova Southeastern University; Nova Southeastern University
Recruiting - verified November 2011 - Condition: HIV Infections
Interventions: Biological: RotaTeq vaccine; Biological: RotaTeq vaccine placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2012 - Conditions: HIV Infections; Drug Abuse
Interventions: Drug: Disulfiram; Drug: Disulfiram + Efavirenz; Drug: Disulfiram + Atazanavir; Drug: Disulfiram + Ritonavir
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institute on Drug Abuse (NIDA)
Recruiting - verified June 2011 - Conditions: Cancer Survivor; Depression; Gastrointestinal Complications; Male Erectile Disorder; Prostate Cancer; Psychosocial Effects of Cancer and Its Treatment; Urinary Complications
Interventions: Behavioral: telephone-based intervention; Other: educational intervention; Other: partner-assisted coping skills training; Other: questionnaire administration; Procedure: psychosocial assessment and care; Procedure: quality-of-life assessment
Sponsors: East Carolina University; East Carolina University; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: HIV Infections
Intervention:
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH)
Recruiting - verified April 2009 - Conditions: Erectile Dysfunction; Lower Urinary Tract Symptoms
Interventions: Drug: Alfuzosin; Drug: Alfuzosin
Sponsors: Chesapeake Urology Research Associates; Chesapeake Urology Research Associates; Sanofi-Aventis
Recruiting - verified February 2012 - Condition: HIV Infections
Interventions: Biological: DNA plasmid vaccine; Biological: Recombinant adenoviral serotype 5 (rAD5) vector vaccine; Biological: DNA vaccine placebo; Biological: HIV-1 recombinant adenovirus vaccine placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); HIV Vaccine Trials Network
Recruiting - verified May 2012 - Condition: HIV Infection
Intervention: Drug: All licensed antiretroviral medications
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; National Institute of Allergy and Infectious Diseases (NIAID); Copenhagen HIV Programme (CHIP) -- Copenhagen, Denmark; Medical Research Council (MRC) Clinical Trials Unit -- London, United Kingdom; Kirby Institute; The Institute for Clinical Research at the Veterans Affairs Medical Center -- Washington, D.C., USA; French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); German Federal Ministry of Education and Research; NEAT - European AIDS Treatment Network; National Health and Medical Research Council, Australia; National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); National Institute of Mental Health (NIMH); National Institute of Neurological Disorders and Stroke (NINDS); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Abbott; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Merck; Tibotec Pharmaceutical Limited
Recruiting - verified April 2012 - Conditions: Parkinson Disease; Huntington Disease; Autistic Spectrum Disorders; Fragile X Syndrome; Alzheimer Disease; Mild Cognitive Impairment
Intervention: Drug: (18F)FPEB
Sponsors: Institute for Neurodegenerative Disorders; Institute for Neurodegenerative Disorders
Recruiting - verified February 2012 - Condition: Brain Injury
Intervention:
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified January 2012 - Condition: Migraine Headache
Interventions: Drug: Treximet (Imitrex + naproxen sodium); Other: Inert Placebo
Sponsors: University of Toledo Health Science Campus; University of Toledo Health Science Campus; GlaxoSmithKline
Recruiting - verified January 2012 - Conditions: Prostate Cancer; Erectile Dysfunction; Urinary Toxicity
Interventions: Drug: LHRH agonist and Bicalutamide; Drug: Bicalutamide, Dutasteride and Tamoxifen
Sponsors: Centre hospitalier universitaire de Québec; Centre hospitalier universitaire de Québec; GlaxoSmithKline
Recruiting - verified February 2012 - Condition: Anterior Ischemic Optic Neuropathy
Intervention: Drug: Diagnostic procedures
Sponsors: Bayer; Bayer
Recruiting - verified May 2012 - Conditions: HIV Infections; Hepatitis C
Interventions: Drug: Alcohol; Drug: Alcohol placebo
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified April 2012 - Conditions: Cervical Cancer; Genital Warts
Intervention:
Sponsors: Duke University; Duke University; Centers for Disease Control and Prevention
Recruiting - verified June 2011 - Condition: Sleep Apnea Syndromes
Intervention: Dietary Supplement: Antioxidant cocktail
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified September 2011 - Conditions: Male Hypogonadism; Androgen Deficiency; Testosterone Deficiency
Intervention: Other: Standard of Care
Sponsors: New England Research Institutes; New England Research Institutes; Bayer
Recruiting - verified July 2011 - Conditions: HIV Infections; Sexually Transmitted Infections
Interventions: Behavioral: Male Sexual Health Program; Behavioral: Focus on the Future Program
Sponsors: University of Kentucky; University of Kentucky; Louisiana State University Health Sciences Center in New Orleans; Carolinas Healthcare System
Recruiting - verified August 2011 - Conditions: Endometriosis; Infertility; Chronic Pelvic Pain; Tubal Ligation
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified November 2011 - Conditions: HIV (Human Immunodeficiency Virus); Metabolic Syndrome; HIV Infections
Intervention: Behavioral: Dietary Intervention
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified June 2011 - Conditions: Acute HIV Infection; HIV Infections
Intervention: Drug: Darunavir/Ritonavir and Etravirine
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; Janssen Pharmaceuticals
Recruiting - verified December 2011 - Conditions: HIV; HIV Infections; Pregnancy
Interventions: Drug: TMC114 (darunavir); Drug: ritonavir; Drug: TMC125 (etravirine); Drug: TMC278 (rilpivirine); Drug: TMC114 (darunavir)
Sponsors: Tibotec, Inc; Tibotec, Inc; Janssen Services, LLC
Recruiting - verified May 2012 - Conditions: HIV; HIV Infections
Intervention: Behavioral: Video
Sponsors: North Bronx Healthcare Network; North Bronx Healthcare Network; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2011 - Conditions: HIV Infection; Inflammation; Cardiovascular Disease; HIV Infections
Interventions: Drug: raltegravir; Drug: Placebo
Sponsors: University of California, San Francisco; University of California, San Francisco; National Heart, Lung, and Blood Institute (NHLBI); Merck
Recruiting - verified November 2011 - Conditions: HIV Infection; Cardiovascular Disease; Inflammation; HIV Infections
Interventions: Drug: Maraviroc; Drug: placebo
Sponsors: University of California, San Francisco; University of California, San Francisco; National Heart, Lung, and Blood Institute (NHLBI); Pfizer
Recruiting - verified November 2011 - Conditions: Low Testosterone Levels; Erectile Dysfunction
Interventions: Drug: Testim® + Viagra®; Drug: Placebo Testim® + Viagra®
Sponsors: Baylor College of Medicine; Mohit Khera
Recruiting - verified December 2011 - Conditions: HIV; Substance Abuse; HIV Infections
Interventions: Behavioral: Intensive Case Management; Drug: Buprenorphine; Behavioral: Money Management
Sponsors: Yale University; Yale University
Recruiting - verified June 2011 - Conditions: HIV; Hyperlipidemia; HIV Infections
Interventions: Drug: ezetimibe; Drug: fenofibrate; Drug: pravastatin
Sponsors: Ospedale di Circolo - Fondazione Macchi; Ospedale di Circolo - Fondazione Macchi; Merck
Recruiting - verified July 2011 - Condition: Obstructive Sleep Apnea
Intervention: Other: physical exercise program
Sponsors: University Hospital, Grenoble; University Hospital, Grenoble; AGIR à Dom
Recruiting - verified April 2012 - Condition: HIV Infections
Intervention:
Sponsors: Radboud University; Radboud University; PENTA Foundation; Merck; Bristol-Myers Squibb; CIHR Canadian HIV Trials Network
Recruiting - verified October 2011 - Condition: Atopic Dermatitis
Interventions: Biological: ROUVAX; Biological: placebo
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Institut National de la Santé Et de la Recherche Médicale, France; Ministry of Health, France
Recruiting - verified December 2011 - Conditions: Depression; Major Depressive Disorder; Cardiovascular Disease; Myocardial Ischemia; Coronary Artery Disease
Intervention:
Sponsors: University of Aarhus; University of Aarhus; The Ministry of Science, Technology and Innovation, Denmark; Vejle Hospital; Danish National Research Foundation; Aarhus University Hospital; Augustinusfonden,
Recruiting - verified March 2012 - Conditions: Cancer; HIV Infections
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified October 2011 - Condition: HIV Infections
Interventions: Drug: Chloroquine; Drug: Placebo
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: Peyronie's Disease
Interventions: Drug: 100 units of BOTOX®; Other: Preservative free normal saline
Sponsors: Baylor College of Medicine; Mohit Khera; Allergan
Recruiting - verified December 2011 - Condition: Cervical Cancer
Intervention: Behavioral: Questionnaires
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified December 2011 - Conditions: Polycystic Ovary Syndrome; Obstructive Sleep Apnea; Obesity
Interventions: Drug: Progesterone; Drug: testosterone; Drug: glucocorticoid; Device: continuous positive airway pressure; Drug: Estrogens
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified February 2012 - Conditions: Acquired Immune Deficiency Syndrome; AIDS; Human Immunodeficiency Virus; HIV Infections
Interventions: Drug: Raltegravir; Drug: Atazanavir; Other: Standard treatment regimen
Sponsors: Yale University; Yale University; Bristol-Myers Squibb; Merck
Recruiting - verified February 2012 - Conditions: Pregnancy; Malaria; HIV Infections
Interventions: Drug: Sulphadoxine-pyrimethamine; Drug: Mefloquine (full dose); Drug: Mefloquine (split dose); Drug: placebo; Drug: mefloquine
Sponsors: Hospital Clinic of Barcelona; Hospital Clinic of Barcelona; Barcelona Centre for International Health Research (CRESIB), Hospital Clinic de Barcelona, Spain; Institute of Tropical Medicine, University of Tuebingen; Institut de Recherche pour le Developpement; Université d'Abomey-Calavi; Albert Schweitzer Hospital; Kenya Medical Research Institute; Ifakara Health Institute (IHI). Ifakara, Tanzania; Centro de Investigacao em Saude de Manhica; Vienna School of Clinical Research (VSCR), Austria.; Centers for Disease Control and Prevention; Malaria in Pregnancy (MiP) Consortium
Recruiting - verified September 2010 - Condition: Pneumonia
Intervention:
Sponsors: UMC Utrecht; UMC Utrecht; Wyeth is now a wholly owned subsidiary of Pfizer
Recruiting - verified April 2012 - Conditions: Chronic Pain; Sexual Dysfunction
Intervention: Procedure: Retro-muscular versus on lay mesh
Sponsors: Skane University Hospital; Skane University Hospital; Region Skane
Recruiting - verified December 2008 - Condition: Acute Coronary Syndromes
Interventions: Procedure: Intravascular ultrasound; Procedure: MRI
Sponsors: New York University School of Medicine; New York University School of Medicine; Doris Duke Charitable Foundation
Recruiting - verified December 2011 - Conditions: HIV Infections; Tuberculosis
Interventions: Drug: Efavirenz (EFV); Drug: Rifampin-containing anti-TB therapy
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2012 - Conditions: Cerebral Toxoplasmosis; AIDS
Intervention: Other: Toxoplasma PCR assay
Sponsors: University Hospital, Limoges; University Hospital, Limoges
Recruiting - verified December 2011 - Condition: HIV Infection
Interventions: Dietary Supplement: Micronutrients and antioxidants; Dietary Supplement: Multivitamins and minerals
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian HIV Trials Network; Ontario HIV Treatment Network
Recruiting - verified July 2011 - Condition: Acute HIV Infection
Intervention:
Sponsors: South East Asia Research Collaboration with Hawaii; South East Asia Research Collaboration with Hawaii; Armed Forces Research Institute of Medical Sciences, Thailand; Thai Red Cross AIDS Research Centre
Recruiting - verified April 2011 - Conditions: HSV-2; HIV; HIV Infections
Interventions: Drug: Valacyclovir; Drug: Placebo
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; GlaxoSmithKline
Recruiting - verified August 2011 - Condition: Andropause
Intervention: Drug: AndroGel® (testosterone gel)
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute on Aging (NIA); National Institute of Neurological Disorders and Stroke (NINDS); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Heart, Lung, and Blood Institute (NHLBI); Abbott
Recruiting - verified January 2012 - Conditions: HIV Infections; HIV-1
Intervention: Drug: TMC278
Sponsors: Tibotec Pharmaceuticals, Ireland; Tibotec Pharmaceuticals, Ireland
Recruiting - verified February 2012 - Conditions: Hepatitis C, Chronic; Cognition Disorders; Fatigue Syndrome, Chronic; Major Depressive Disorder
Interventions: Drug: Interferon and ribavirin; Drug: Interferon Alfa-2a + ribavirin
Sponsors: University of Aarhus; Aarhus University Hospital
Recruiting - verified December 2011 - Condition: Acute HIV Infection
Interventions: Drug: Anti-HIV Agents; Drug: Anti-HIV Agents
Sponsors: South East Asia Research Collaboration with Hawaii; South East Asia Research Collaboration with Hawaii; Thai Red Cross AIDS Research Centre; Pfizer; Gilead Sciences; Merck
Recruiting - verified April 2011 - Conditions: HIV Infections; AIDS; Opportunistic Infections
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: Bacterial Vaginosis
Interventions: Drug: Gelatin; Drug: Boric acid; Drug: Metronidazole
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified April 2012 - Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: Maraviroc
Sponsors: ViiV Healthcare; ViiV Healthcare; Pfizer
Recruiting - verified May 2012 - Conditions: HIV Infection; HIV Seronegativity
Intervention:
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - verified November 2010 - Condition: HIV Infections
Intervention:
Sponsors: South East Asia Research Collaboration with Hawaii; South East Asia Research Collaboration with Hawaii; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified October 2008 - Condition: Systemic Lupus Erythematosus
Interventions: Drug: N-acetylcysteine; Drug: N-acetylcysteine; Drug: Placebo
Sponsors: State University of New York - Upstate Medical University; State University of New York - Upstate Medical University
Recruiting - verified January 2012 - Conditions: Cardiovascular Disease; HIV Infections
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2012 - Condition: HIV Infections
Intervention:
Sponsors: South East Asia Research Collaboration with Hawaii; South East Asia Research Collaboration with Hawaii
Recruiting - verified September 2008 - Condition: HIV Infection
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2011 - Condition: Non Small Cell Lung Carcinoma
Intervention:
Sponsors: European Lung Cancer Working Party; European Lung Cancer Working Party
Recruiting - verified June 2011 - Conditions: WAGR Syndrome; Wilm's Tumor; Aniridia; Urogenital Abnormalities; Mental Retardation
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified June 2011 - Condition: Human Immunodeficiency Virus Infections
Intervention: Behavioral: Questionnaire
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified April 2012 - Condition: Gynecologic Diseases
Interventions: Procedure: Laparoscopic supracervical hysterectomy; Procedure: Total laparoscopic hysterectomy
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital
Recruiting - verified May 2012 - Conditions: HIV; AIDS; Tuberculosis
Interventions: Drug: Simultaneous ARV and antiMTB; Drug: Deferred RV and antiMTB treatment
Sponsors: Instituto Nacional de Enfermedades Respiratorias; Instituto Nacional de Enfermedades Respiratorias; Consorcio de Investigación sobre VIH/SIDA/TB (CISIDAT).
Recruiting - verified August 2008 - Conditions: HIV Infections; Malaria
Interventions: Drug: Lamivudine; Drug: Lopinavir/Ritonavir; Drug: Nevirapine; Drug: Zidovudine
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2012 - Conditions: Substance Abuse; HIV Infections
Interventions: Behavioral: contingency management; Behavioral: contingency management
Sponsors: University of Connecticut Health Center; University of Connecticut Health Center; National Institute on Drug Abuse (NIDA)
Recruiting - verified November 2011 - Conditions: Rectal Cancer; Rectum
Interventions: Behavioral: questionnaires; Behavioral: CSI-SH- Cancer Survivorship Intervention
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Albert Einstein College of Medicine of Yeshiva University; Mount Sinai School of Medicine; M.D. Anderson Cancer Center; National Institutes of Health (NIH)
Recruiting - verified March 2012 - Condition: Alcoholic Intoxication
Interventions: Drug: Alcohol; Procedure: Self-Administration
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified February 2012 - Condition: Polycystic Ovary Syndrome
Interventions: Drug: Orlistat (Alli) and Lifestyle Intervention with exercise and diet; Drug: Loestrin 1/20; Drug: Orlistat (Alli) and Loestrin 1/20
Sponsors: Penn State University; Penn State University; University of Pennsylvania
Recruiting - verified November 2011 - Conditions: Aids-related Malignancies; Lymphoma; Precancerous Condition; Sarcoma
Interventions: Genetic: polymerase chain reaction; Other: cytology specimen collection procedure; Other: histological technique; Procedure: colposcopic biopsy
Sponsors: AIDS Malignancy Clinical Trials Consortium; AIDS Malignancy Clinical Trials Consortium; National Cancer Institute (NCI)
Recruiting - verified November 2011 - Conditions: Smoking; HIV Infections
Interventions: Drug: Varenicline tartrate; Drug: Nicotine Replacement Therapy; Other: Biological Control; Behavioral: Motivational Interview
Sponsors: Ohio State University; Ohio State University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified August 2011 - Condition: Chronic Pelvic Pain Syndrome
Interventions: Device: combined sono-electro-magnetic therapy (Sonodyn Medico Star); Device: placebo therapy (Placebo Sonodyn Medico Star)
Sponsors: University Hospital Inselspital, Berne; University Hospital Inselspital, Berne
Recruiting - verified December 2011 - Conditions: Chronic Prostatitis With Chronic Pelvic Pain Syndrome; Chronic Bacterial Prostatitis; Asymptomatic Inflammatory Prostatitis; Painful Bladder Syndrome; Cystitis, Interstitial
Intervention: Genetic: Genomic and proteomic biomarker discovery
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center
Recruiting - verified June 2011 - Conditions: Aging; Insulin Resistance
Interventions: Drug: Testosterone; Drug: Estrogen
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified January 2012 - Condition: HIV Infections
Intervention: Drug: ARV regimen chosen by treating physician
Sponsors: University of North Carolina, Chapel Hill; Kristine Patterson, MD; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2012 - Conditions: Oropharyngeal Cancer; Head and Neck Cancer; Squamous Cell Carcinoma
Intervention: Behavioral: Questionnaire
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified February 2012 - Condition: Bacterial Vaginosis
Interventions: Other: No Intervention; Drug: Metronidazole
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Conditions: HIV Infections; Hyperlipidemia
Intervention: Drug: Atorvastatin
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2012 - Condition: Human Immunodeficiency Virus
Interventions: Drug: Maraviroc along with an optimized background antiretroviral drug regimen; Drug: Optimized background antiretroviral drug regimen without maraviroc
Sponsors: ViiV Healthcare; ViiV Healthcare; Pfizer
Recruiting - verified May 2012 - Condition: HIV Infections
Interventions: Drug: Treatment initiation for HIV-1 group O infected patients; Drug: Treatment initiation for HIV-1 group M infected patients
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - verified March 2012 - Conditions: HIV Infections; Tuberculosis
Interventions: Drug: rifabutin in combination with lopinavir boosted by ritonavir - dosing schedule 1; Drug: rifabutin in combination with lopinavir boosted by ritonavir - dosing schedule 2
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - verified October 2011 - Conditions: Type 1 Diabetes; Osteoporosis
Intervention:
Sponsors: Creighton University; Creighton University
Recruiting - verified October 2011 - Condition: Fecal Incontinence
Interventions: Procedure: caesarean section; Procedure: vaginal delivery
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified February 2008 - Condition: HIV Infections
Intervention: Procedure: Male Circumcision
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - verified March 2012 - Condition: HIV Infections
Interventions: Biological: DermaVir patch; Biological: Placebo patch
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Not yet recruiting - verified May 2012 - Condition: HIV Infections
Interventions: Drug: lopinavir/ritonavir (LPV/r); Drug: Lamivudine (3TC)
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research on AIDS and Viral Hepatitis; European and Developing Countries Clinical Trials Partnership (EDCTP); The Research Council of Norway; Swedish International Development Cooperation Agency (SIDA); Université Montpellier; University of Bergen
Recruiting - verified January 2012 - Condition: Vaginal Cancer
Intervention: Behavioral: QOL
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified January 2012 - Conditions: Prostate Cancer; Quality of Life
Intervention: Behavioral: Quality of Life Questionnaires
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; The Cleveland Clinic
Recruiting - verified December 2011 - Condition: HIV Infections
Interventions: Dietary Supplement: Meat Biscuit; Dietary Supplement: Soy Biscuit; Dietary Supplement: Wheat Biscuit
Sponsors: Indiana University; Indiana University School of Health & Rehabilitation Sciences; United States Agency for International Development (USAID); Moi Univeristy; University of California, Los Angeles; Heifer Project International
Recruiting - verified September 2009 - Condition: HIV Infections
Intervention: Drug: Cell Transfer
Sponsors: National Institutes of Health Clinical Center (CC); National Institutes of Health Clinical Center (CC)
Recruiting - verified February 2012 - Conditions: Ovariectomy; Hysterectomy; Hypoactive Sexual Desire Disorder
Intervention:
Sponsors: Center for Epidemiology and Health Research, Germany; Center for Epidemiology and Health Research, Germany; Procter and Gamble
Recruiting - verified October 2011 - Conditions: Gastrointestinal Complications; Prostate Cancer; Sexual Dysfunction; Urinary Complications
Interventions: Drug: bicalutamide; Drug: goserelin acetate; Drug: leuprolide acetate; Procedure: adjuvant therapy; Procedure: quality-of-life assessment; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Medical Research Council
Recruiting - verified July 2009 - Condition: Pneumothorax
Intervention:
Sponsors: Shaare Zedek Medical Center; Shaare Zedek Medical Center
Recruiting - verified September 2007 - Condition: Sitosterolemia
Intervention: Behavioral: High/Low Sitosterol
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified August 2011 - Conditions: Leukemia; Myelodysplastic Syndrome
Intervention: Behavioral: Interview
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: HIV Infections
Intervention:
Sponsors: Microbicide Trials Network; Microbicide Trials Network; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2011 - Conditions: Burning Mouth Syndrome; Taste Disorder; Orofacial Pain
Intervention:
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany; Deutsche Gesellschaft für Zahn-, Mund- und Kieferheilkunde e.V.
Recruiting - verified June 2011 - Condition: Heart Disease
Intervention: Procedure: Blood Sample
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified May 2012 - Condition: Schizophrenia
Interventions: Drug: Oxytocin; Drug: Placebo
Sponsors: University of California, San Diego; University of California, San Diego; Stanley Medical Research Institute
Recruiting - verified September 2010 - Conditions: Chronic Prostatitis (CP); Chronic Pelvic Pain Syndrome (CPPS); Painful Bladder Syndrome (PBS); Benign Frequency Syndrome (BFS); Benign Daytime Frequency Syndrome (BDFS)
Intervention:
Sponsors: Children's Hospital Boston; Children's Hospital Boston; National Institutes of Health (NIH)
Recruiting - verified July 2011 - Condition: Cancer of the PROSTATE
Interventions: Procedure: Radical retropubic prostatectomy; Procedure: Radical laparoscopy prostatectomy
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified January 2008 - Conditions: HIV Infections; Tuberculosis
Interventions: Drug: Antiretroviral medications; Drug: Antiretroviral medications+Isoniazid prophylaxis; Drug: Antiretroviral medications; Drug: Antiretroviral medications+Isoniazid prophylaxis
Sponsors: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); French National Agency for Research on AIDS and Viral Hepatitis; Gilead Sciences; Merck
Recruiting - verified March 2012 - Conditions: Hypogonadism; Kallmann Syndrome; Puberty, Delayed; Puberty, Precocious; Hypothalamic Amenorrhea; Anosmia; GnRH Deficiency
Intervention:
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Conditions: Kallmann Syndrome; Idiopathic Hypogonadotropic Hypogonadism; GnRH Deficiency
Intervention: Drug: gonadotropin releasing hormone (GnRH)
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); William Crowley
Recruiting - verified February 2012 - Condition: HIV Infections
Interventions: Drug: Raltegravir (MK-0518); Drug: Raltegravir (MK-0518); Drug: Raltegravir (MK-0518)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Conditions: Understanding of Early Settings to an Obesity "Career"; Vascular Burden in Obesity; Brown/White Adipose Tissue; Adipokines; Fatty Liver Disease; Insulin Resistance
Intervention: Other: Lifestyle modification
Sponsors: Medical University of Graz; Medical University of Graz; Zukunftsfond Steiermark; Bundesministerium für Gesundheit, Familie und Jugend; Steiermärkische Landesregierung; Graz University of Technology; Karl-Franzens University of Graz; Paracelsus Medical University; Technische Universität München
Recruiting - verified April 2012 - Conditions: Turner Syndrome; Ovarian Failure, Premature; Sex Chromosome Aberrations; Menopause; Perimenopause
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Eye Institute (NEI)
Recruiting - verified October 2009 - Condition: Acculturation
Intervention: Behavioral: Questionnaire
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified March 2012 - Condition: HIV Infections
Interventions: Drug: Zidovudine, Stavudine, Didanosine, Lamivudine; Drug: Nevirapine, Efavirenz; Drug: LPV/r, Saquinavir, Indinavir, Ritonavir, Nelfinavir
Sponsors: The HIV Netherlands Australia Thailand Research Collaboration; The HIV Netherlands Australia Thailand Research Collaboration; Khon Kaen University
Recruiting - verified April 2012 - Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Bill and Melinda Gates Foundation
Recruiting - verified May 2012 - Conditions: HIV-Dementia; HIV-Associated Cognitive Motor Complex; AIDS Encephalopathy; AIDS Dementia Complex; AIDS-Related Dementia Complex; HIV Infections; Healthy
Intervention: Drug: [11C]PBR28
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified August 2011 - Conditions: HIV Infections; Lipodystrophy
Intervention: Drug: Metreleptin (Leptin)
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; Amylin Pharmaceuticals, Inc.
Recruiting - verified August 2011 - Conditions: Amenorrhea; Hypogonadotropic Hypogonadism; Kallmann's Syndrome
Intervention: Procedure: Frequent baseline blood sampling
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institutes of Health (NIH)
Recruiting - verified April 2012 - Conditions: HIV Infections; Coronary Atherosclerosis
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Bristol-Myers Squibb
Recruiting - verified February 2012 - Conditions: Oral Hygiene; HIV Infections; Mouth Diseases
Intervention: Behavioral: Case-management linkage intervention
Sponsors: University of Miami; University of Miami; National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified January 2012 - Condition: Lymphoma
Interventions: Biological: bleomycin sulfate; Drug: carmustine; Drug: cyclophosphamide; Drug: cytarabine; Drug: dacarbazine; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: etoposide phosphate; Drug: ifosfamide; Drug: melphalan; Drug: prednisolone; Drug: prednisone; Drug: procarbazine hydrochloride; Drug: vinblastine sulfate; Drug: vincristine sulfate; Procedure: autologous hematopoietic stem cell transplantation; Radiation: fludeoxyglucose F 18; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Martin-Luther-Universität Halle-Wittenberg
Recruiting - verified June 2007 - Condition: HIV Infections
Intervention:
Sponsors: Institut de Recherche pour le Developpement; Institut de Recherche pour le Developpement; Global Fund; Ministry of Health, Thailand
Recruiting - verified January 2012 - Condition: Benign Prostatic Hyperplasia (BPH)
Intervention: Device: Prolieve® Thermodilatation System
Sponsors: Boston Scientific Corporation; Boston Scientific Corporation
Recruiting - verified June 2011 - Conditions: Kallmann Syndrome; Hypogonadotropic Hypogonadism; GnRH Deficiency
Intervention: Drug: gonadotropin releasing hormone (GnRH)
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2011 - Conditions: Hypogonadotropic Hypogonadism; Amenorrhea; Kallmann's Syndrome
Interventions: Drug: synthetic gonadotropin releasing hormone (GnRH); Device: Mini-infusion pump
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified April 2012 - Conditions: Prostatic Neoplasms; Prostate Cancer
Intervention:
Sponsors: Stanford University; Stanford University
Recruiting - verified May 2012 - Conditions: HIV Infections; Papillomavirus Infections; Anal Intraepithelial Neoplasia
Intervention: Behavioral: Smear and biopsy testing for HPV-types and viral load
Sponsors: Deutsche Luft und Raumfahrt; Deutsche Luft und Raumfahrt
Recruiting - verified January 2009 - Condition: Fragile X Syndrome
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified January 2012 - Condition: Klinefelter Syndrome
Interventions: Drug: androgen oxandrolone; Other: placebo
Sponsors: Thomas Jefferson University; Thomas Jefferson University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified July 2011 - Conditions: Thyroid Cancer; Thyroid Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Prostate Cancer
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified November 2011 - Condition: HIV
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified July 2011 - Condition: Lung Cancer
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified November 2011 - Condition: HIV Infections
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: Epilepsy
Intervention:
Sponsors: King's College London; King's College London; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified August 2011 - Condition: Cervical Cancer
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified July 2011 - Conditions: Breast Cancer; Cancer Survivor; Depression; Fatigue; Sexual Dysfunction; Sleep Disorders; Spiritual Concerns
Interventions: Other: study of socioeconomic and demographic variables; Procedure: fatigue assessment and management; Procedure: management of therapy complications; Procedure: psychosocial assessment and care; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Indiana University Melvin and Bren Simon Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2007 - Conditions: AIDS-Related Primary Central Nervous System Lymphoma; HIV
Interventions: Drug: Methotrexate; Biological: rituximab; Procedure: antiviral therapy; Drug: leucovorin calcium
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified January 2012 - Condition: Turner Syndrome
Intervention: Drug: Somatropin
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified April 2012 - Conditions: Excess Androgen; Congenital Adrenal Hyperplasia (CAH); Familial Male-Limited Precocious Puberty (FMPP)
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified March 2012 - Condition: Glanzmann Thrombasthenia
Intervention:
Sponsors: Rockefeller University; Rockefeller University
Recruiting - verified January 2012 - Conditions: Substance-Related Disorders; Sexual Risk Behaviors
Intervention: Behavioral: Motivational interviewing
Sponsors: Boston Medical Center; Boston Medical Center; National Institute on Drug Abuse (NIDA)
Recruiting - verified October 2011 - Conditions: Autonomic Failure; Orthostatic Hypotension
Interventions: Drug: Atomoxetine; Drug: Acarbose; Drug: Pyridostigmine Bromide; Drug: Yohimbine; Drug: Midodrine HCl; Drug: placebo; Drug: Modafinil; Drug: Octreotide; Other: water intake; Drug: Diphenhydramine Hydrochloride; Drug: Ranitidine HCL; Drug: Tranylcypromine; Drug: Ergotamine/ Caffeine; Drug: Celecoxib; Drug: Pseudoephedrine; Drug: Methylphenidate; Drug: Indomethacin; Drug: Ibuprofen; Drug: Oxymetazoline 0.05% nasal solution; Dietary Supplement: Bovril; Drug: Acetazolamide; Drug: Rivastigmine tartrate; Drug: Carbidopa/levodopa; Device: abdominal binder; Device: abdominal binder (sham)
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Conditions: Drug Abuse; HIV Infections
Intervention:
Sponsors: University of Florida; University of Florida; National Institute on Drug Abuse (NIDA); Johns Hopkins University
Recruiting - verified March 2012 - Condition: Autonomic Dysreflexia
Intervention: Drug: Prazosin HCL
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011 - Condition: HIV Infections
Intervention: Procedure: blood draw
Sponsors: Rockefeller University; Rockefeller University
Recruiting - verified January 2012 - Condition: HIV Infections
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2012 - Condition: Prostate Cancer
Intervention: Drug: luteinizing hormone-releasing hormone (LHRH) short acting or long acting
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified February 2012 - Condition: HIV Infection
Intervention: Drug: Efavirenz
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Available - verified February 2012 - Condition: HIV Infection
Intervention: Drug: Efavirenz
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Available - verified January 2012 - Conditions: Birth Defects; Pregnancy Complications; Hepatitis C
Intervention:
Sponsors: INC Research; INC Research; Aurobindo; Genentech; Sandoz Inc.; Merck; Teva Pharmaceuticals USA; Kadmon Pharmaceuticals, LLC; Zydus Pharmaceuticals USA, Inc.
Recruiting - verified October 2011 - Conditions: Accelerated Phase Chronic Myelogenous Leukemia; Acute Undifferentiated Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Primary CNS Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Blastic Phase Chronic Myelogenous Leukemia; Burkitt Lymphoma; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Grade III Lymphomatoid Granulomatosis; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Eosinophilic Leukemia; Chronic Myelomonocytic Leukemia; Chronic Neutrophilic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Essential Thrombocythemia; Extramedullary Plasmacytoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; HIV Infection; HIV-associated Hodgkin Lymphoma; Intraocular Lymphoma; Isolated Plasmacytoma of Bone; Juvenile Myelomonocytic Leukemia; Mast Cell Leukemia; Meningeal Chronic Myelogenous Leukemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Polycythemia Vera; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Primary Central Nervous System Lymphoma; Primary Myelofibrosis; Primary Systemic Amyloidosis; Progressive Hairy Cell Leukemia, Initial Treatment; Prolymphocytic Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Splenic Marginal Zone Lymphoma; Stage 0 Chronic Lymphocytic Leukemia; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Hodgkin Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Adult T-cell Leukemia/Lymphoma; Stage I Childhood Anaplastic Large Cell Lymphoma; Stage I Childhood Hodgkin Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Lymphoblastic Lymphoma; Stage I Childhood Small Noncleaved Cell Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Multiple Myeloma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage I Small Lymphocytic Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage II Adult T-cell Leukemia/Lymphoma; Stage II Childhood Anaplastic Large Cell Lymphoma; Stage II Childhood Hodgkin Lymphoma; Stage II Childhood Large Cell Lymphoma; Stage II Childhood Lymphoblastic Lymphoma; Stage II Childhood Small Noncleaved Cell Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Multiple Myeloma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Childhood Anaplastic Large Cell Lymphoma; Stage III Childhood Hodgkin Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Multiple Myeloma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Childhood Anaplastic Large Cell Lymphoma; Stage IV Childhood Hodgkin Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific; Waldenstrom Macroglobulinemia
Interventions: Drug: fludarabine phosphate; Drug: cyclosporine; Drug: mycophenolate mofetil; Procedure: allogeneic bone marrow transplantation; Procedure: peripheral blood stem cell transplantation; Radiation: total-body irradiation
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Conditions: Hepatitis C; HIV Infections
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Conditions: Endometriosis; Pelvic Pain; Healthy; Tubal Ligation
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified April 2012 - Conditions: Autosomal Recessive Polycystic Kidney Disease; Congenital Hepatic Fibrosis; Caroli's Disease; Polycystic Kidney Disease; Joubert Syndrome; Cerebro-Oculo-Renal Syndromes; COACH Syndrome; Senior-Loken Syndrome; Dekaban-Arima Syndrome; Cogan Oculomotor Apraxia; Nephronophthisis; Bardet-Biedl Syndrome; Alstrom Syndrome; Oral-Facial-Digital Syndrome
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified March 2012 - Condition: HIV Infections
Intervention: Drug: Tipranavir
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Available - verified May 2012 - Condition: HIV Infections
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: HIV Infections
Intervention: Drug: Current ARV medications
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2012 - Condition: HIV Infections
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2011 - Conditions: HIV Seronegativity; HIV Infections
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2011 - Conditions: Dystonia; Healthy
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified March 2012 - Condition: HIV Infections
Intervention:
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cisplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: lomustine; Drug: vincristine sulfate
Sponsors: National Cancer Institute (NCI); Children's Hospital of Philadelphia
Recruiting - verified June 2009 - Conditions: Perimenopausal Depression; Depression
Interventions: Drug: Raloxefine (Evista); Drug: Rimostil; Drug: Evista, Rimostil, Alora
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified September 2011 - Condition: HIV Infections
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2011 - Conditions: HIV Infections; Pregnancy Complications, Infectious
Intervention: Behavioral: Adherence assessment
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2012 - Conditions: Cancer; HIV Infection; Skin Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified March 2012 - Conditions: HIV Infection; Kaposi's Sarcoma
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified September 2011 - Conditions: AIDS Related Lymphoma; HIV Infection
Interventions: Biological: Rituximab; Biological: filgrastim; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: vincristine sulfate
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified December 2011 - Condition: Turner's Syndrome
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Adrenal Gland Neoplasm
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified September 2011 - Condition: Hepatitis C
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institutes of Health Clinical Center (CC)
Recruiting - verified January 2012 - Condition: HIV Infections
Intervention:
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Conditions: Coronary Disease; Obesity
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2011 - Conditions: Autoimmune Disease; Congenital Adrenal Hyperplasia; Healthy; Mental Disorder Diagnosed in Childhood; Neurologic Manifestations
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified September 2011 - Conditions: Acquired Immunodeficiency Syndrome; Neoplasm; Skin Disease; HIV Infections
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified March 2012 - Conditions: Acquired Immunodeficiency Syndrome; Neoplasm; Skin Disease; HIV Infections
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified January 2012 - Conditions: AIDS Associated Nephropathy; Focal Glomerulosclerosis; HIV Infections
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified July 2011 - Conditions: AIDS Associated Nephropathy; Focal Glomerulosclerosis; HIV Infections
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified September 2011 - Condition: HIV Infection
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID); Washington Hospital Center
Recruiting - verified January 2012 - Conditions: HIV Infection; Viremia
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Conditions: HIV Infection; Immunologic Deficiency Syndrome
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: HIV Infection
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2011 - Condition: Pregnancy
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified November 2011 - Condition: HIV Infection
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2012 - Conditions: HIV Infection; Neoplasm
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified May 2012
 |
Join Clinical Trials for Sexual Diseases in |
